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ABSTRACT OF DISSERTATION

NONINVASIVE ASSESSMENT AND MODELING OF DIABETIC
CARDIOVASCULAR AUTONOMIC NEUROPATHY
Noninvasive assessment of diabetic cardiovascular autonomic
neuropathy (AN): Cardiac and vascular dysfunctions resulting from AN are
complications of diabetes, often undiagnosed. Our objectives were to: 1)
determine sympathetic and parasympathetic components of compromised blood
pressure regulation in patients with polyneuropathy, and 2) rank noninvasive
indexes for their sensitivity in diagnosing AN. Continuous 12-lead
electrocardiography (ECG), blood pressure (BP), respiration, regional blood flow
and bio-impedance were recorded from 12 able-bodied subjects (AB), 7 diabetics
without (D0), 7 with possible (D1) and 8 with definite polyneuropathy (D2), during
10 minutes supine control, 30 minutes 70-degree head-up tilt and 5 minutes
supine recovery. During the first 3 minutes of tilt, systolic BP decreased in D2
while increased in AB. Parasympathetic control of heart rate, baroreflex
sensitivity, and baroreflex effectiveness and sympathetic control of heart rate and
vasomotion were reduced in D2, compared with AB. Baroreflex effectiveness
index was identified as the most sensitive index to discriminate diabetic AN.
Four-dimensional multiscale modeling of ECG indexes of diabetic
autonomic neuropathy: QT interval prolongation which predicts long-term
mortality in diabetics with AN, is well known. The mechanism of QT interval
prolongation is still unknown, but correlation of regional sympathetic denervation
of the heart (revealed by cardiac imaging) with QT interval in 12-lead ECG has
been proposed. The goal of this study is to 1) reproduce QT interval prolongation
seen in diabetics, and 2) develop a computer model to link QT interval
prolongation to regional cardiac sympathetic denervation at the cellular level.
From the 12-lead ECG acquired in the study above, heart rate-corrected QT
interval (QTc) was computed and a reduced ionic whole heart mathematical
model was constructed. Twelve-lead ECG was produced as a forward solution
from an equivalent cardiac source. Different patterns of regional denervation in
cardiac images of diabetic patients guided the simulation of pathological changes.
Minimum QTc interval of lateral leads tended to be longer in D2 than in AB.

Prolonging action potential duration in the basal septal region in the model
produced ECG and QT interval similar to that of D2 subjects, suggesting
sympathetic denervation in this region in patients with definite neuropathy.

KEYWORDS: blood pressure regulation, spectral power, baroreflex, twelve-lead
ECG, forward solution
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Part 1.

Noninvasive assessment of diabetic

cardiovascular autonomic neuropathy
1.1 Chapter One: Introduction
Neuropathy is one of the complications of diabetes. Diabetic neuropathy
affects sensory, motor and autonomic nerves. Cardiovascular autonomic
neuropathy (CAN) is a common and serious type of neuropathy, that involves the
damage of both sympathetic and parasympathetic branches of autonomic nerves
innervating the heart and blood vessels, causing abnormal regulation of heart
rate and vascular dynamics (128).
The pathogenesis of neuropathy in diabetic patients is still not clear.
Current hypotheses concerning the multiple etiologies of diabetic neuropathy
include metabolic insult to nerve fibers, neurovascular insufficiency, autoimmune
damage and neurohormonal growth factor deficiency, resulting in nerve
degeneration or gene-related neural damage (128, 130). The prevalence of CAN
has been determined to be 25.3% for individuals with Type 1 diabetes and 34.3%
for individuals with Type 2 diabetes, as diagnosed by clinical cardiovascular
reflex tests currently in use (see below) (143).
Cardiovascular autonomic neuropathy is associated with increased risk of
occurrence of cardiac events including myocardial infarction, heart failure,
ventricular tachycardia or fibrillation (128). The 5-year mortality of diabetics with
CAN is three times higher than in diabetics without CAN (128). The quality of life
was decreased in diabetic patients with severe CAN due to orthostatic
hypotension, amputation, or other symptoms. Treatment of cardiovascular
manifestations of diabetic autonomic neuropathy includes intensive glycemic
control to prevent the onset of diabetic autonomic neuropathy and slow the
progression (129) . In addition, a variety of treatments are available to alleviate
the symptoms of autonomic neuropathy (130). The onset of CAN occurs early in
diabetes, and patients are usually asymptomatic for years and are not able to
1

sense when they are becoming hypoglycemic or having a heart attack (130).
Early diagnosis and treatment is the key to effectively treating CAN.
Current clinical tests of CAN rely on a battery of cardiovascular reflex tests
called Ewing tests (39). Although useful, these tests require voluntary
participation and the sensitivity of these tests is limited. For example, the direct
measure of cardiac sympathetic innervation determined from
metaiodobenzylguanidine (MIBG) scintigraphy revealed that abnormal cardiac
sympathetic innervation occurred earlier than previously known from Ewing, and
other, tests and, in fact, was evident in diabetic patients whose Ewing tests were
still normal (49). However, MIBG scintigraphy is expensive, invasive and time
consuming, and is thus not suitable for routine screening of CAN. In the last two
decades, alterations in power spectral analysis of heart rate variability have been
related to abnormal Ewing tests in diabetic patients, reflecting mostly
parasympathetic dysfunction (32, 45, 60, 144).
1.1.1 Objective
The present study aimed to assess the function of both sympathetic and
parasympathetic braches of the autonomic nervous system in diabetic patients,
in order to develop indexes suitable for screening of diabetic autonomic
neuropathy. Passive head-up tilt was used to stimulate autonomic regulation of
cardiovascular responses to orthostatic stress. Cardiovascular variables were
acquired from able-bodied subjects, diabetic patients without neuropathy,
diabetic patients with mild neuropathy and diabetic patients with severe
neuropathy. The specific goals of this study were to 1) assess dysfunction of
autonomic regulation of cardiovascular system in diabetic patients, 2) develop
indexes of diabetic cardiovascular autonomic neuropathy that are noninvasive,
sensitive, cost-effective and easy to acquired and 3) further explore mechanisms
of autonomic regulation of the cardiovascular system of normal humans by
comparing with autonomic failure in diabetics.

2

In this study, 12-lead ECG was also acquired to assess cardiac function in
supine diabetic patients. Because of the lack of cardiac imaging data of
sympathetic innervation, a heart-torso computer model was developed to assess
dysfunction of sympathetic innervation of the heart in diabetic patients. Because
of the extended length of the content, 12-lead ECG and modeling are included in
Part 2 of this document. Part 1 focuses on blood pressure regulation in diabetic
and nondiabetic subjects in response to head-up tilt.

3

1.2 Chapter Two: Background
1.2.1 Physiological Response to Orthostatic Stress
Demands for autonomic regulation of blood pressure at supine position
are minimum, therefore passive head-up tilt (47) was used to activate autonomic
regulation by challenging the cardiovascular system during exposure to gravity
while minimizing activation of postural muscles, primarily the legs. The
hydrostatic pressure gradient along the length of the body, due to the drag of
gravity, increases transmural pressure of the vessels below the heart, thus
increasing venous volume by approximately 500 mL (79). In healthy subjects,
reflexes elicited by the unloading of arterial baroreceptors and cardiopulmonary
mechanoreceptors restore blood pressure rapidly. The reflexes act by increasing
heart rate, contractility and vascular resistance. After the initial response,
hormonal regulation predominates in blood pressure regulation by further
vasoconstriction and maintaining plasma volume. These responses are
described in detail below.
Arterial baroreceptors and cardiopulmonary receptor are sensory stretch
receptors, which sense arterial and cardiac filling pressures. This information is
transmitted to the brainstem where it is integrated with information from other
sensors. Sympathetic and parasympathetic outflows from the brainstem are
adjusted to initiate the desired cardiovascular response. These reflexes function
via negative feedback (79).
The cardiac pre-ganglionic parasympathetic fibers synapse the postganglionic parasympathetic fibers near the heart. Parasympathetic fibers
innervate the sinoatrial (SA) and atrioventricular (AV) nodes. Post-ganglionic
parasympathetic fibers release the neurotransmitter acetylcholine (ACh) from the
nerve terminal, which acts by binding to muscarinic M2-receptors on the myocyte
membrane (79). ACh slows the pacemaker potential decay and hyperpolarizes
the membrane, resulting in slowing of heart rate. ACh reduces the pacemaker
slope via an inhibitory G protein-adenylate cyclase-cAMP-PKA pathway. On the
4

other hand, the hyperpolarizing effect of ACh is mediated through a G-proteinKACh channel pathway, which is a rapid pathway. ACh is quickly removed from
the junctional region by the enzyme cholinesterase. These mechanisms account
for the rapidity of the response, with which vagal stimulation slows the heart and
the reduction of vagal activity speeds the heart, within one heart beat (79).
The efferent cardiac pre-ganglionic sympathetic fibers arise from the
thoracic spinal cord, segments T1 – T5, and synapse in the sympathetic chain.
The post-ganglionic fibers innerve the SA node, the AV node, and the
myocardium of atria and ventricles. Post-ganglionic sympathetic fibers release
the neurotransmitter norepinephrine (NE), which binds to adrenergic receptors in
the heart. There are α-, β and β –receptors in the heart, while β receptors
1

2

1

predominate. Activation of the β receptors induces the following effects over
1

several beats: increased heart rate, increased AV node conduction velocity,
shortened myocyte action potential, increased contractile force and increased
rate of relaxation. These responses are induced by β receptors activating the
1

cAMP-PKA pathway, which leads to changes in ion channel and pump activity.
The termination of the action of NE is partly by diffusion into the bloodstream,
which washes it away; and partly by reuptake into the sympathetic nerves. The
slow activation and termination processes explain the slow response to, and
recovery from, sympathetic stimulation. Epinephrine, which is secreted into the
bloodstream by the medulla of the adrenal gland in response to preganglionic
sympathetic fiber activity, acts in a similar way as NE at the heart (79).
In addition to the control of the heart, sympathetic neural activity controls
vascular resistance by controlling the contraction and relaxation of vascular
smooth muscle (VSM) cells. The post-ganglionic sympathetic neurotransmitter,
NE, binds to α-adrenoreceptors on the membrane of VSM cells. Activation of αadrenoreceptors induces VSM contraction by increasing cytosolic free [Ca2+],
due to 1) sustained membrane depolarization through PLC-IP3-DAG pathway in
many arteries, 2) firing of action potentials in response to strong sympathetic
5

stimulation in arterioles, small arteries and veins, and 3) mechanisms
independent of membrane depolarization in large arteries. Activation of
sympathetic fiber is tonic, and reduced sympathetic activity results in vasodilation
(79).
Within the first few minutes of head-up tilt, healthy persons usually have
an initial drop in blood pressure, sensed by arterial baroreceptors and
cardiopulmonary receptors, which rapidly bring back blood pressure by
withdrawal of parasympathetic outflow and an increase in sympathetic outflow.
Withdrawal of parasympathetic outflow to the heart causes an increase of heart
rate. Increased sympathetic outflow to the heart results in increases of heart rate
and heart contractility. In addition, increased sympathetic outflow to peripheral
vasculature causes constriction of resistance vessels and thus an increase in
total peripheral resistance. At the capillary level, constriction of arterioles causes
decreased hydrostatic pressure thereby increasing osmotic absorption of
interstitial fluid in to the plasma compartment which helps to increase blood
return. Finally, increased sympathetic outflow results in venoconstriction, which
can displace blood from the big reservoirs in the intestinal tract, liver and skin (79,
109).
During longer head-up tilt, regulation by hormones predominates. The
effective hormones at different times are epinephrine, norepinephrine, renin,
angiotensin II, aldosterone, vasopressin, etc, to vasoconstrict and maintain
plasma volume (109).
It should be noted that skin is an important organ in both regulation of
blood pressure and thermoregulation. In human, approximately 95% of the skin is
hairy skin and the other 5% is non-hairy skin which is primarily at palmar surface
of the hands, soles of the feet and part of the face (59). Circulations in both types
of skin are controlled by the sympathetic nervous system: hairy skin is controlled
by both cholinergic (active vasodilation) and adrenergic (vasoconstriction)
branches of the sympathetic nerves and non-hairy skin is controlled by
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adrenergic (vasoconstriction) sympathetic nerves (21). Arteriovenous
anastomoses (AVA) are present in the non-hairy skin and are innervated by
adrenergic sympathetic nerves which are tonically active, while in hairy skin, AVA
rarely exist (21). It was reported that there is a reflex vasoconstriction in hairy
skin in response to head-up tilt, while the non-hairy skin is not involved in this
response (109).
1.2.2 Detection of Diabetic CAN
The damage of nerve fibers in autonomic neuropathy is believed to be
length dependent. It occurs earliest in parasympathetic fibers which are longer
fibers, followed by damage in shorter sympathetic fibers (128, 130). Ewing tests
were developed several decades ago and serve as a noninvasive measure of
cardiovascular autonomic neuropathy in both branches (39). Ewing tests consist
of 5 reflex tests, including heart rate response to Valsalva maneuver, heart rate
variation during deep breathing, immediate heart rate response to standing,
(controlled predominantly by parasympathetic nerves), blood pressure response
to standing and blood pressure response to sustained handgrip, (controlled
predominantly by sympathetic nerves) (39). If the results of two or more of these
tests are abnormal, the patient is diagnosed to have CAN. Although it is useful in
detection of cardiovascular autonomic neuropathy, this battery of tests requires
voluntary participation of patients and involves specialized operations from heath
care providers. In addition, its manifestations lag behind abnormalities in
spontaneous baroreflex function (44) and cardiac imaging of sympathetic
innervation to the myocardium (49).
A direct measure of cardiac sympathetic innervation to the myocardium
can be performed by using a radio-labeled norepinephrine analog and
tomography of uptake of this analog into nerve terminals. The most commonly
used neuronal tracers are MIBG, used with single photon emission computed
tomography (SPECT), and 11C-meta-hydroxyephedrine (HED), used with
positron emission tomography (PET) (63). In normal human subjects, cross
sections of MIBG-SPECT or HED-PET images demonstrated homogeneous
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uptake of tracer and a complete ventricular structure, while in diabetic patients,
reduced tracer uptake in the whole left ventricle or regions of the left ventricle
have been observed, even in those without signs of neuropathy (22, 49, 56, 75,
91, 93, 112-115, 123). These techniques provide insight to sympathetic
innervation of the heart, although they are not suitable for routine screening.
Other techniques are being examined for their potential to provide in-depth,
easy to administer, diagnostic tools. Comparisons of heart rate variability, low (LF)
and high (HF) frequency components of heart rate oscillations, have been
correlated with abnormal results of Ewing tests (32, 45, 60, 144). Diabetic
patients with abnormal Ewing results also demonstrated reduced LF spectral
power of systolic blood pressure compared to able bodied controls or compared
to diabetics with normal results in Ewing tests, during one hour supine or a short
period of standing (32, 144). In diabetics with no signs of autonomic neuropathy,
the numbers of spontaneous baroreflex sequences were reduced and slopes of
baroreflex sequences were smaller compared to controls (32, 44). Heart rate
variability and baroreflex sequences, acquired during a short period of time,
demonstrate parasympathetic dysfunction in modulating heart rate in diabetic
patients. Longer recordings of blood pressure revealed sympathetic dysfunction
in modulating peripheral vasculature. The ultimate goal of this study is to develop
indexes of both sympathetic and parasympathetic function from noninvasive
recordings taken over a short period of time.
1.2.3 Models of Autonomic Failure
Studies of sino-aortic denervated (SAD) animals (cats and dogs), a form of
‘dysautonomia’, showed that not only were harmonic components (LF or HF
peaks) of heart rate and blood pressure oscillations affected by SAD, but
nonharmonic components were also altered over a wide frequency range (very
low, low and high frequencies) (29, 133). In addition to the alteration in heart and
blood pressure variability over a wide frequency range, the baroreflex
effectiveness index, which represents the percentage of systolic blood pressure
(SBP) ramps followed by reflex RR interval responses to all SBP ramps, was
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reduced by 89% in SAD cats (31). In humans with pure autonomic failure, heart
rate and blood pressure variability have been shown to be altered at all
frequencies (97). Finally, we reported previously that spinal cord injury resulted
in reduced baroreflex effectiveness index in tetraplegic patients compared to able
bodied controls (5). Results of these previous human and animal studies
indicated similarities between diabetic autonomic neuropathy, sinoaortic
denervation and primary autonomic failure that appeared to be proportional to the
level of neuropathy and observable in noninvasive indexes of autonomic function.
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1.3 Chapter Three: Methods
1.3.1 Subjects
Twelve healthy able-bodied volunteers (AB) were recruited from the local
community using word of mouth, newspaper advertisements and flyers mounted
on boards across the university campus and hospital. Twenty-two diabetic
subjects were recruited. The diabetic subjects were evaluated at the day of
study by Dr. Kevin Nelson, Department of Neurology, UK College of Medicine, for
distal symmetrical polyneuropathy using neuropathic symptoms, depressed ankle
reflexes, distal sensory loss, distal muscle weakness or atrophy, and nerve
conduction studies (18). Subjects were then distinguished by consensus criteria
that determined the likelihood of neuropathy using an ordinal scale from highest
4 to lowest 1 (35). ‘Possible neuropathy’ was defined by a likelihood ranking of
two or three, and ‘definite neuropathy’ by the likelihood of 4. Diabetic subjects
without neuropathy had no signs or symptoms of neuropathy, in addition to
normal nerve conduction studies. Based upon the results of these evaluations
the neuropathy of diabetic subjects was categorized as absent (D0), possible
(D1) or definite (D2). In addition to the tests for peripheral neuropathy, and for
fasting blood glucose levels on the day of study, all subjects underwent a
familiarization tilt and 12 lead ECG. Medications affecting autonomic function
were discontinued for the day of study. Demographic characteristics of the
participants are shown in Table 1.
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Table 1 Demographic characteristics of participants

Ablebodied
(AB)
48.2 ± 3.9
93.0 ± 9.0
171.5 ± 3.0
12 (5/7)

Age, yr
Weight, kg
Height, cm
n (Male/Female)
n of Type 1/ Type 2
Values are means ± SEM

No
Peripheral
Neuropathy
(D0)
39.7 ± 5.6
84.2 ± 8.1
164.6 ± 3.0
7 (1/6)
3/4

Diabetic
Possible
Peripheral
Neuropathy
(D1)
53 ± 4.1
110.7 ± 15.9
176.8 ± 4.6
7 (5/2)
2/5

Definite
Peripheral
Neuropathy
(D2)
55.1 ± 2.7
97.9 ± 11.4
174.2 ± 3.3
8 (5/3)
3/5

1.3.2 Tilt Protocol
We utilized passive head-up tilt to challenge the autonomic regulation of
arterial blood pressure. Before entering the study all subjects gave written
informed consent and the protocol was approved by the University of Kentucky
Institutional Review Board. Prior to head-up tilt testing, subject’s height, age,
weight and diabetic status were recorded. Later, after blood glucose level had
been determined, an IV cannula was placed in an antecubital vein. Subjects
then rested in the supine position for 30 min when instrumentation was applied
followed by 10 minutes of supine control and 30 minutes of 70-degree head-up
tilt. If presyncopal symptoms developed during tilt, subjects were brought back to
supine immediately. All subjects were followed for a supine recovery period of
five minutes.
1.3.3

Measured Variables
Mixed venous blood samples were drawn from the antecubital vein

catheter at the end of control, at three and seven min of tilt, and during the
second minute of recovery. Results of blood assays, body fluid shifts and
impedance measures of cardiac output are not reported here, but are
components of the next manuscript, see Future Work.
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Lead II ECG (Pilot Colin) was acquired from three electrodes. Noninvasive
continuous arterial blood pressure (BP, Portapres model-2) was acquired from a
cuff placed at finger. Respiratory activity (Respitrace) was acquired by measuring
respiratory inductance plethysmography with two bands enclosed chest and
abdomen. Two laser Doppler probes (Perimed) were placed at two skin sites:
one on the palm of hand (non-hairy skin) and the other on the forearm (hairy
skin). The measuring depth of the probe was 0.5 – 1 mm with the fiber separation
0.25 mm and the wavelength of the laser 780 nm (77, 121). Fluid shifts between
body segments were assessed by measuring bio-impedance (UFI THRIM) of
thorax, abdomen, upper leg and lower leg. Tilt angle (Crossbow CXL 04LP3) was
acquired from an accelerometer mounted on the tilt table. Recordings were
commenced during supine control, and continued uninterrupted during the 70
degree head-up tilt and supine recovery. The blood pressure sensor was
maintained at heart level. Manual blood pressure using an arm cuff was
acquired at the end of supine control, the beginning of tilt and at the end of
recovery. The hand with blood pressure finger cuff and laser Doppler probe was
covered by a mitten, in order to keep the hand warm and allow for a measurable
blood pressure signal during the whole study. A 12-lead ECG was acquired from
supine subjects breathing at 15 breaths/min. Data acquisition of 12-lead ECG
lasted for approximately 5 min or until at least 256 heart beats were recorded for
signal averaging. Room temperature was maintained at 22 ± 0.25oC (mean ±
SEM), ranging from 20.6-23.9 oC.
1.3.4 Data Acquisition and Analysis
Blood pressure, ECG, respiratory activity, skin perfusion, bio-impedance
and tilt angle recordings were digitized at 1000 Hz by using a commercial data
acquisition system (DATAQ). 12-lead ECGs were digitized at 1000 Hz and
recorded by using a commercial device and software (Cardiax).
Mean values. Heart rate (HR) and RR interval were computed by
identifying R waves in the last 5 min of control, 0-3 min, 3-7 min, and 7-12 min of
tilt and the first 3 min of recovery. Data were analyzed using custom written
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programs in C++ and MATLAB (the MathWorks, Natick, MA). Artifacts in HR and
BP signals, including premature beats and Portapres servo adjustments
(approximately 5% of the beats per time series), were manually removed. The
cleaned signals were then aligned in time. Systolic (SBP) and diastolic (DBP)
blood pressures were determined by computing the maximum and minimum
values of clean arterial BP for each heart beat. Beat-to-beat skin perfusion
sequences were determined by integrating the pulsatile skin perfusion between
two R waves. Mean values of RR interval, SBP, DBP and skin perfusions of palm
and forearm were computed in each time segment. All subsequent data analyses
were performed in MATLAB.
Spectral analysis. RR interval, SBP, DBP and skin perfusions in control,
tilt and recovery periods were resampled at 4 Hz using a cubic spline. Power
spectral densities of RR interval, SBP and DBP were analyzed in the last 5 min
of control, 0-3 min, 3-7 min, and 7-12 min of tilt and the first 3 min of recovery.
Power spectral densities of skin perfusions were analyzed in 10 min of control
and the first 10 min of tilt to acquire a better accuracy at lower frequencies. Each
segment was then linearly detrended. Power spectral densities were estimated
using Welch's method of averaged periodograms (480-point Hamming windows
with 440-point overlap). Spectral powers of RR interval, SBP and DBP in the LF
(0.04-0.15 Hz) and HF (0.15-0.4 Hz) regions were obtained using trapezoidal
integration over the specified frequency range. Spectral power of DBP was used
as an index of sympathetic control of vasomotion because DBP correlated better
than did SBP with vascular resistance (13). Power spectral density of SBP,
however, was used as an index of baroreflex-mediated buffering of blood
pressure. Power spectral densities were plotted in a log-power vs. log-frequency
scale, and the slope of the linear regression of this plot within the LF range was
calculated. This power law scaling relationship was quantified for RR interval,
SBP and DBP to determine their harmonic and nonharmonic characteristics (34,
50). The magnitudes of the power spectral density of skin perfusions were
determined from the mean value of the logarithm of the power spectral density in
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specific frequency regions: very low frequency (VLF, 0.004-0.04 Hz), low
frequency (LF, 0.04 -0.15 Hz) and high frequency (HF, 0.15-0.4 Hz).
Coherences. The coherences between skin perfusions and blood pressure
were analyzed across 10 min of control and the first 10 min of tilt. The 95%
confidence level of non-zero coherence was estimated by the following method.
If the theoretical coherence between the input and output signals of a linear timeinvariant system is zero, then the random variable
2
(𝑣 − 2)𝑟𝑥𝑦
(𝑓)
2
2(1 − 𝑟𝑥𝑦 (𝑓))

is approximately distributed with an F distribution 𝑓2,𝑣−2, where r2xy is the squared
coherence between skin perfusion and blood pressure, and 𝑣 is the degree of
freedom associated with Hamming window, which was estimated by
𝑁

𝜈 = 2.51 𝑀.

2M is the window length and N is the data length. Therefore, we have
2 (𝑓)
(𝑣−2)𝑟𝑥𝑦

2 (𝑓))
2(1−𝑟𝑥𝑦

= 𝑓2,𝑣−2

<1>

Rearranging <1> and replacing the f function in <1> with its 95% critical value
give the 95% confidence level of non-zero coherence as
𝑟2 =

2𝑓2,𝑣−2 (0.95)
(𝑣 − 2) + 2𝑓2,𝑣−2 (0.95)

Because able-bodied subjects and diabetics without neuropathy had
similar skin perfusion responses to head-up tilt, and diabetics with possible and
those with definite neuropathy had similar responses, able-bodied subjects and
diabetics without neuropathy were combined into one, non-neuropathy, group,
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and diabetics with possible and those with definite neuropathy were combined
into one neuropathy group.
Baroreflex sequences. The sequence method (12) was adopted to quantify
the number of blood pressure ramps and baroreflex sequences, as well as
baroreflex sensitivity. Sequences of three or more consecutive heartbeats were
identified, in which progressively increasing (or decreasing) SBP with at least 1
mmHg beat-to-beat change were followed within 1 heart beat by progressively
lengthening (or shortening) of RR interval with at least 4 msec beat-to-beat
change. A sequence was accepted as a baroreflex sequence if the correlation
coefficient of the regression line between SBP and RR interval within the
sequence was 0.85 or greater (12). The slope of the regression line for each
sequence was taken as spontaneous baroreflex sensitivity (BRS). The ratio
between the number of baroreflex sequences and the total number of increasing
or decreasing SBP ramps determined the baroreflex effectiveness index (BEI)
(31). Because the numbers of SBP ramps and baroreflex sequences depend on
the number of analyzed heartbeats, which varied among and within subjects, the
numbers of SBP ramps and baroreflex sequences were normalized by the
number of analyzed heartbeats of each subject in each time segment.
Arterial pulse transit time. An index of arterial compliance, arterial pulse
transit time (PTT), was measured by adapting the technique of Foo et al. (42).
Arterial PTT was recorded as the time interval between the R peak in ECG and
the SBP peak in the arterial pressure measured at the finger. Average values
from ten beats selected from clean data were taken in the last minute of supine
control and the second minute of 70-degree head-up tilt.
Statistical analysis. SAS (The SAS Institute, Cary, NC) software was used
to test a linear mixed model for differences within and among four groups (ablebodied, diabetic without neuropathy, diabetic with possible neuropathy, diabetic
with definite neuropathy) during supine control, at three time segments during tilt,
and in recovery. The group factor was used to test differences among the four
15

groups. The time factor was used to test the tilt effect. The group × time factor
was used to test for differences in tilt effects across groups. The changes from
control to the first three minutes of tilt were tested with one-way ANOVA and twotail t tests. For a priori hypothesized differences between variables, for which we
predicted a specific difference (greater or less) before we analyzed the data,
changes from control were analyzed using one-tail t tests. Data were transformed
by using logarithm or square root if the residual plots showed heteroscedasticity.
Nonparametric test, the Mann-Whitney U test, was used to test the changes from
supine control to tilt when the distribution of data did not meet the requirement of
t test. Outliers were identified if residuals were larger than two standard
deviations and thus were not included in the statistical testing. Differences were
considered significant if p ≤ 0.05. Results are presented as mean ± SEM.
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1.4 Chapter Four: Results
Upon testing, one able-bodied subject was diagnosed with nondiabetic
sensory and motor neuropathy; his data were not included in any group. Five
able-bodied subjects, and three diabetics with possible neuropathy demonstrated
symptoms of presyncope before finishing 30 min of head-up tilt and were
returned to supine immediately.
Typical RR interval, arterial BP, skin perfusion of palm and forearm, and tilt
angle of an asymptomatic able-bodied subject and a diabetic patient with definite
neuropathy during supine and during 30 min head-up tilt are shown in Figure 1.1.
In the nonsyncopal, able bodied subject, RR interval decreased and BP
increased modestly during head-up tilt. In the same subject, skin perfusion of
palm increased and skin perfusion of forearm decreased during head-up tilt. In
the diabetic patient with definite neuropathy, RRI decreased to a smaller extent
and BP decreased during head-up tilt. In the same subject, skin perfusion of
palm was higher than that in the able-bodied subject at control and did not
increase during head-up tilt. Skin perfusion of forearm of this subject also
decreased during head-up tilt.
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Figure 1.1 Typical RR interval, arterial blood pressure and skin perfusions
of palm and forearm during 10 min supine control, 30 min 70-degree headup tilt and 5 min recovery, in an able-bodied subject (left), and a diabetic
subject with definite neuropathy (right).

1.4.1 Mean Values
Figure 1.2 shows group averaged (± SEM) RR interval and SBP for ablebodied (AB; blue line) subjects, diabetics without neuropathy (D0; pink line),
diabetics with possible neuropathy (D1; red line) and diabetics with definite
neuropathy (D2; dark red line). Data are given for supine control, three stages of
tilt and supine recovery. All groups decreased RR interval (Figure 1.2A) in
response to head-up tilt. The magnitudes of SBP responses to the first three
minutes of head-up tilt (Figure 1.2B2) were significantly different between ablebodied subjects and diabetics with definite neuropathy (one-tailed t-test); for
able-bodied, SBP increased from 124 ± 5.8 mmHg in supine control to 132 ± 7.9
mmHg; for diabetics with definite neuropathy, SBP decreased from 128.7 ± 7.8
18

mmHg in supine control to 119.2 ± 10.7 mmHg. Supine control values of RR
interval and SBP were not different between the groups.

Figure 1.2 Average ± SEM RR interval (Figure A) and systolic blood
pressure (Figure B1) for able-bodied subjects (AB; n=11), diabetics without
neuropathy (D0; n=6), diabetics with possible neuropathy (D1; n=5) and
diabetics with definite neuropathy (D2; n=8) in response to head up tilt.
Figure B2 shows changes of SBP from supine control to the first 3 min of
tilt. Δ, significantly different from control (same group); •, significantly
different from AB (same time segment); *, significantly different from D0
(same time segment).
Figure 1.3 shows group averaged (± SEM) skin perfusion of the forearm
for combined groups of subjects without neuropathy (able-bodied and diabetics
without neuropathy) and those with neuropathy (diabetics with possible and
definite neuropathy). Skin perfusion of forearm decreased in both groups (tilt
main effect, p = 0.0078) during all time segments of head-up tilt compared to
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control and recovery. The neuropathy group tended to have higher skin perfusion
of forearm than the non-neuropathy group (group main effect, p = 0.189, Figure
1.3). We interpret this tendency to be due to the larger number of male subjects
in the neuropathy group compared to the non-neuropathy group (Figure 1.4).
Male subjects had higher skin perfusion than did females in both groups at
control (gender main effect P<0.05 in two-way ANOVA with the factors of gender
and presence of neuropathy).

Figure 1.3 Average ± SEM skin perfusion of the forearm in the nonneuropathy group [able bodied (AB), diabetics without neuropathy (D0)],
and the neuropathy group [diabetics with possible neuropathy (D1) and
diabetics with definite neuropathy (D2)] during 5 min of supine control, 0-3
min, 3-7 min, 7-12 min and the last 3 min of head-up tilt and during 3 min of
supine recovery.
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Figure 1.4 Gender differences in average ±SEM skin perfusion of the
forearm in non-neuropathy (AB+D0, left) and neuropathy (D1+D2, right)
groups during 5 min of supine control, 0-3 min, 3-7 min, 7-12 min and the
last 3 min of head-up tilt and during 3 min of supine recovery.

Figure 1.5 shows group averaged (± SEM) skin perfusion of the palm for
combined non-neuropathy and neuropathy groups. Skin perfusion of palm was
significantly higher in the neuropathy group than in the non-neuropathy group
during supine control. Skin perfusion of the palm of the non-neuropathy group
increased significantly after the third minute of head-up tilt, while skin perfusion of
the palm of the neuropathy group decreased during the first 3 min of head-up tilt.
During recovery, palmar skin perfusion of the non-neuropathy group was higher
than control, while that of neuropathy group was not different from control. Group
differences in response to head-up tilt are easier to see, when palmar skin
perfusion is plotted as tilt-induced changes from control (Figure 1.6). The
changes of palmar skin perfusion in the neuropathy group were significantly
different from those in the non-neuropathy group after the third minute of head-up
tilt and during recovery. When each group was further divided into male and
female subjects, gender differences were not significant either in the control
values or in the responses to head-up tilt (Figure 1.7).
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Figure 1.5 Average ± SEM skin perfusion of the palm of the hand in the nonneuropathy (AB and D0) and neuropathy (D1 and D2) groups during 5 min
of supine control, 0-3 min, 3-7 min, 7-12 min and the last 3 min of head-up
tilt and during 3 min of supine recovery. ●, significantly different between
groups in the same time segment. Δ, significantly different from control in
the same group.

Figure 1.6 Average ± SEM changes from control of palmar skin perfusion
for non-neuropathy (AB and D0) and neuropathy (D1 and D2) groups during
0-3 min, 3-7 min, 7-12 min and the last 3 min of head-up tilt and during 3
min of supine recovery. ●, significantly different between groups in the
same time segment. Δ, significantly different from the first 3 min of tilt in
the same group.
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Figure 1.7 Gender differences in average ±SEM skin perfusion of the palm
in non-neuropathy (AB+D0, left) and neuropathy (D1+D2, right) groups
during 5 min of supine control, 0-3 min, 3-7 min, 7-12 min and the last 3 min
of head-up tilt and during 3 min of supine recovery.

1.4.2 Spectral Power
Figure 1.8 gives average high frequency spectral power of RR interval
(HFRRI, Panel A, left) and low frequency spectral power of diastolic blood
pressure (LFDBP, Panel B1, upper right) for each of the four groups. In Figure
1.8A, HFRRI decreased during head-up tilt for all groups. In addition, able-bodied
subjects and diabetics without neuropathy had higher HFRRI than did diabetics
with definite neuropathy (group main effect). Figure 1.8B1 shows that diabetics
with possible neuropathy and those with definite neuropathy tended to have
lower LFDBP than did able-bodied subjects and diabetics without neuropathy
during head-up tilt (group × time, p=0.06). The change in LFDBP during the first
3 min of tilt, Figure 1.8B2, differed significantly (p<0.05) between able-bodied
(2.1 ± 0.4 mmHg2 supine, to 4.9 ± 1.6 mmHg2) and diabetics with definite
neuropathy (2.1 ± 0.5 mmHg2 supine, to 1.6 ± 0.7 mmHg2).
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Figure 1.8 Panel A: Average ± SEM spectral power of RR interval in the
high-frequency region for able-bodied subjects (AB; n = 11), diabetics
without neuropathy (D0; n = 6), diabetics with possible neuropathy (D1; n=5)
and diabetics with definite neuropathy (D2; n =8) at rest and in response to
head-up tilt. Panel B1: The spectral power of DBP in the low-frequency
region for the four groups in response to head-up tilt. These group
differences in response to the first 3 min of tilt are shown in Figure B2. •,
significantly different from AB; *, significantly different from D0.

Figure 1.9 shows group averaged log of power spectral density of SBP
(PSD SBP; Figure 1.9A and Figure 1.9B, top) and log of RR interval (PSD RRI;
Figure 1.9D and Figure 1.9E bottom) versus log of frequency for able-bodied
subjects (left panels) and diabetics with definite peripheral neuropathy (middle
panels). The analyses are from recordings taken during five minutes of supine
control. Data shown are means (solid lines) ± SEM (shaded area above and
below the mean). Spectral power of SBP was significantly greater (four fold,
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which is not immediately evident on logarithmic scales) in diabetics with definite
neuropathy than in able-bodied subjects (Figure 1.9B vs. Figure 1.9A) across the
very low frequency (0.003 - 0.04 Hz) and high frequency (0.15 - 0.4 Hz) regions.
However, in contrast to able-bodied subjects, the SBP spectral power of
diabetics with definite neuropathy dipped at frequencies around 0.1 Hz (Figure
1.9B). In addition, the slope of the linear portion of this SBP curve in the low
frequency region tended to be steeper in diabetics with definite neuropathy (-2.64
± 0.44) than in able-bodied subjects (-1.54 ± 0.37) (Figure 4C). SBP powers for
diabetics without, and those with, possible neuropathy, were similar to that of
able-bodied subjects (not shown). In contrast to SBP, the variability of RR
interval for diabetics with definite neuropathy was significantly (four fold) lower
than that of able-bodied subjects over the range of frequencies (0.003 - 0.4 Hz)
(Figure 1.9D vs. Figure 1.9E). Log-log plots of RRI for diabetics without
neuropathy and diabetics with possible neuropathy were intermediate between
able-bodied subjects and diabetics with definite neuropathy (not shown). Slopes
of the log-log RR interval/frequency curve were significantly steeper in the low
frequency region (0.04 - 0.15Hz) in diabetics with possible (-2.19 ± 0.35) and
definite neuropathy (-2.77 ± 0.24) than slopes of able-bodied (-1.05 ± 0.35) and
diabetics without neuropathy (-1.15 ± 0.4), Figure 1.9F.
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Figure 1.9 Average ± SEM logarithm of power spectral density of systolic
blood pressure (PSD SBP) and RR interval (PSD RRI) taken from 5 min
supine control (means shown in solid lines and SEM shown in shaded area
above and below the mean in A, B, D and E). Plots A and B show log (PSD
SBP) vs log (f) for AB (n = 11) and D2 (n=8) respectively. Plot C shows the
average value of the slopes of the linear portion of log (PSD SBP) vs log (f)
curves in the low frequency (0.04 - 0.15 Hz, LF) region for all four groups.
Plots D and E show log (PSD RRI) vs log (f) for AB and D2 respectively. Plot
F shows the average value of the slopes of log (PSD RRI) vs log (f) curves
in the low frequency. •, significantly different from AB; *, significantly
different from D0.
Figure 1.10 shows power spectral density (PSD) of diastolic blood
pressure (DBP) on a logarithmic scale, during 10 min supine control (left panel)
and the first 10 min of tilt (right panel) in non-neuropathy (blue) and neuropathy
(red) groups. The PSD of DBP demonstrated similar response to that shown in
Figure 1.8B, but with a more obvious difference between the two groups. During
head-up tilt the mean magnitude of PSD in the low frequency region increased in
the non-neuropathy group but did not change in the neuropathy group. In
addition, mean LF PSD was lower in the neuropathy group than in the non-
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neuropathy group. High frequency PSD of DBP decreased from control to tilt in
the neuropathy group.

Figure 1.10 Average ± SEM logarithm of power spectral density of diastolic
blood pressure taken from10 min supine control and the first 10 min of
head-up tilt. ●, significantly different between groups in the same time
segment. Δ, significantly different from control in the same group.
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Figure 1.11 shows PSD of skin perfusion of the forearm on a logarithmic
scale, during 10 min supine control (left panel) and the first 10 min of tilt (right
panel) in non-neuropathy and neuropathy groups. Low frequency PSD
decreased during tilt in the neuropathy group but did not change in the nonneuropathy group (group × time interaction p=0.03). The changes of mean LF
PSD of skin perfusion of the forearm from control to tilt are shown in Figure 1.12.
The change of LF PSD was significantly different between the non-neuropathy
and neuropathy groups (Mann-Whitney Test, p = 0.05). The group difference was
more obvious in the frequency range between 0.075 and 0.1 Hz (time × group
interaction, p= 0.02; the non-neuropathy group tended to be greater than the
neuropathy group during tilt, p = 0.1). In the high frequency region, mean PSD in
the neuropathy group was higher than that in the non-neuropathy group in control
and decreased during tilt (Figure 1.11, group × time interaction, p=0.012).

Figure 1.11 Average ± SEM logarithm of power spectral density of skin
perfusion of forearm taken from10 min supine control and the first 10 min
of head-up tilt. ●, significantly different between groups in the same time
segment. Δ, significantly different from control in the same group.
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Figure 1.12 Change of mean low frequency PSD of skin perfusion of the
forearm from control to the first 10 min of head-up tilt. P = 0.05, MannWhitney Test.
Figure 1.13 shows the power spectral density of skin perfusion of palm on
a logarithmic scale, during 10 min supine control and the first 10 min of tilt in nonneuropathy and neuropathy groups. Mean magnitude of PSD in the very low
frequency region decreased in both groups from control to tilt (main tilt effect).
High frequency PSD tended to decrease in the neuropathy group but did not
change in the non-neuropathy group (group × time interaction p=0.06).
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Figure 1.13 Average ± SEM logarithm of power spectral density of skin
perfusion of palm taken from10 min supine control and the first 10 min of
head-up tilt.
1.4.3 Coherences
Coherences between skin perfusion of the forearm and SBP during 10 min
supine control and 10 min tilt for non-neuropathy and neuropathy groups are
shown in Figure 1.14. At control, coherences between skin perfusion and SBP in
the low frequency region were significant in the non-neuropathy group and were
at the borderline of significance in the neuropathy group. In response to tilt,
coherences in the low frequency region increased in the non-neuropathy group
but decreased in the neuropathy group. At respiratory frequencies, coherences
were significant in the neuropathy group in control and tilt. In the non-neuropathy
group, coherences at respiratory frequencies were not significant during control,
but approached significance during tilt. The responses were similar in the
coherence between skin perfusion of forearm and DBP (Figure 1.15).
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Figure 1.14 Average ± SEM coherence of skin perfusion of forearm and
systolic blood pressure during 10 min supine control and the first 10 min of
head-up tilt. Horizontal lines: 95% confidence level of non-zero coherence.

Figure 1.15 Average ± SEM coherence of skin perfusion of forearm and
diastolic blood pressure during 10 min supine control and the first 10 min
of head-up tilt. Horizontal lines: 95% confidence level of non-zero
coherence.
The LF coherence between skin perfusion of the palm and SBP was not
significant during supine control in both groups, but increased during tilt in the
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non-neuropathy group. The LF coherence did not change in the neuropathy
group (Figure 1.16). At respiratory frequencies, coherences were significant in
the neuropathy group in control and tilt. In the non-neuropathy group, coherences
at respiratory frequencies were not significant during control, but approached
significance during tilt. The responses were similar in the coherence between
skin perfusion of palm and DBP (Figure 1.17).

Figure 1.16 Average ± SEM coherence of skin perfusion of palm and
systolic blood pressure during 10 min supine control and the first 10 min of
head-up tilt. Horizontal lines: 95% confidence level of non-zero coherence.

32

Figure 1.17 Average ± SEM coherence of skin perfusion of palm and
diastolic blood pressure during 10 min supine control and the first 10 min
of head-up tilt. Horizontal lines: 95% confidence level of non-zero
coherence.
1.4.4 Baroreflex Sequences
Figure 1.18 provides the normalized number of SBP ramps (A),
normalized number of baroreflex sequences (B), baroreflex effectiveness index
(BEI; C), baroreflex slope (D) and high frequency spectral power of systolic blood
pressure (HFSBP; E) for each of the four groups. In supine control, both
diabetics with possible, and those with definite, neuropathy had greater numbers
of SBP ramps than did able-bodied subjects (Figure 1.18A). During head-up tilt,
diabetics with definite neuropathy also had more SBP ramps than did diabetics
without neuropathy during all three time segments, most clearly illustrated at 7-12
min of tilt. However, diabetics with definite neuropathy had a significantly smaller
number of baroreflex sequences than did able-bodied subjects and diabetics
without neuropathy (group main effect; Figure 1.18B). As a result, BEI values for
diabetics with possible, and for those with definite, neuropathy were significantly
lower than those for able-bodied subjects and diabetics without neuropathy
during head-up tilt (Figure 1.18C). One able-bodied subject had BEI residuals
larger than 2 standard deviations at all time segments. When this subject’s data
were excluded from the analysis, the group x time interaction became significant.
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Other factors remained significant with or without exclusion of this subject, with
no effect on the direction of the results. In addition, baroreflex slope significantly
decreased in all groups in response to head-up tilt (Figure 1.18D). Diabetics with
possible neuropathy had significantly lower baroreflex slopes than able-bodied
subjects, and diabetics with definite neuropathy had significantly lower slopes
than both able-bodied subjects and diabetics without neuropathy (group main
effect). Finally, the diminution of baroreflex activity to buffer breathing frequency
blood pressure oscillations in diabetics with definite neuropathy is illustrated in
Figure 1.18E indicating a four fold greater magnitude of HFSBP oscillations in
those subjects compared to the other groups (similar to the results illustrated in
Figure 1.9 A and B).
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Figure 1.18 Baroreflex regulation: Average ± SEM normalized number of
SBP ramps (A), normalized number of baroreflex sequences (B), baroreflex
effectiveness index (C), baroreflex slope (D), and high frequency spectral
power of SBP (E) for AB (n = 11), D0 (n=6), D1 (n=5) and D2 (n=8) at rest and
in response to head-up tilt. Δ, significantly different from control (same
group); •, significantly different from AB (same time segment); *,
significantly different from D0 (same time segment).
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1.4.5 Gender
Because of known gender differences in autonomic regulation of heart
rate (parasympathetic dominance in high frequency power of heart rate in women
compared to men) and peripheral vasculature (sympathetic dominance in control
of vascular regulation in men) (7, 37, 52, 80), we examined heart rate, blood
pressure and baroreflex variables for gender differences. The results of these
analyses indicated that, for these groups, gender effects were obscured by
effects of diabetes (data not shown).
1.4.6 Arterial Pulse Transit Time (PTT)
Arterial PTT was not significantly different among the four groups in supine
or during the second minute of tilt, nor the tilt-induced increases of PTT were
significantly different among the four groups.
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1.5 Chapter Five: Discussion
1.5.1 Mean Values of Blood Pressure and RR Interval
The inability of diabetics to increase, or even maintain, blood pressure
during tilt (Figure 1.2), indicated that sympathetic pathways to cardiovascular
effectors were impaired in diabetics with peripheral neuropathy compared to
able-bodied subjects. In healthy humans, orthostatic stress induces
vasoconstriction at the arteriolar level, which increases absorption of fluid into the
plasma. The drop of blood pressure in diabetic patients with definite neuropathy,
and the lack of increase of blood pressure in diabetic patients without or with mild
neuropathy during the first three minutes of tilt, may reflect impairment of normal
orthostatic vasoconstriction (109). Moreover, the importance of the baroreflex in
regulating blood pressure over longer time periods is illustrated in the very low
frequency region of Figure 1.9. These results also support the comment made by
many of the patients that they had learned to move slowly into the upright
position and if they move slowly they are okay. The slow speed (approximately
38 seconds to move from supine to 70 degrees head up) of our tilt was probably
responsible for the fact that presyncopal symptoms were relatively rare in our
diabetic subjects.
1.5.2 Mean Values of Skin Perfusion
In all subjects, the skin perfusion of the palm was higher than that of the
forearm as expected (62), an effect related to the presence of arteriovenous
anastomoses in the microcirculation of the non-hairy skin (79). A higher
evaporation rate from the skin of the palm of hand than that from the forearm at a
thermoneutral environment has also been reported (57).
In the current study, in response to head-up tilt, the skin perfusion of the
forearm decreased in the subjects without neuropathy, as expected (4, 62, 84,
109, 111, 117). The neuropathy group had similar responses to head-up tilt
compared to the non-neuropathy group, indicating a normal reflex adrenergic
control of cutaneous vasoconstriction, or the withdrawal of cholinergic control of
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vasodilation in the forearm, in the neuropathy group (58). However, the
neuropathy group tended to have a greater skin perfusion of the forearm at all
time segments. This was probably due to a larger number of male subjects in this
group compared to the non-neuropathy group, since men tended to have higher
skin perfusion than did women in both groups as shown in Figure 1.4.
In the palm, the mean skin perfusion in the non-neuropathy group did not
change during the first 3 min of head-up tilt (Figure 1.1), supporting the absence
of vasoconstriction in the hand during orthostasis (109). It was also reported that
direct baroreflex stimulations on carotid sinus nerve did not have discernible
effect on the outflow of the skin sympathetic nerve (134). In the present study,
the unchanged skin perfusion of the palm during the first 3 min of head-up tilt
may be due to a lack of increase in sympathetic outflow during orthostasis. After
the first 3 min of head-up tilt, skin perfusion of the palm increased in the nonneuropathy group (Error! Reference source not found., Figure 1.6). We
interpret this increase to be due to an increase of core temperature, previously
observed in both men and women during graded head-up tilt to 60 degrees (84).
Therefore, vasoconstriction of hairy skin during head-up tilt (Figure 1.3) appears
to be acting to prevent heat loss (109). If core temperature increases, as a result
of hairy skin vasoconstriction to preserve blood pressure, the vasomotor drive to
AVAs from the hypothalamus could be reduced and thereby provide a
mechanism to shunt blood to the skin for cooling through AVA dilation, increasing
blood flow and allowing heat dissipation (109). This hypothesis is consistent with
our observations from the non-neuropathy group. Alternatively, or in addition to
prevention of heat loss, metabolic rate has been shown to rise during head up tilt
(20).
Johnson et al. (65) have shown that adrenergic blockade by bretylium
increased baseline palmar skin blood flow. In patients with familial dysautonomia,
baseline skin blood flow at finger pulp tended to be higher than that in healthy
subjects (121). This study also reported that sinusoidal neck suction at 0.1 Hz
caused reduction in skin blood flow at finger pulp in healthy control subjects,
38

while the reduction of pulpar finger blood flow was much smaller in patients with
familial dysautonomia (121). In our study, elevated control values of palmar skin
perfusion in the neuropathy group, compared to the non-neuropathy group, may
reflect impaired tonic sympathetic control of vasoconstriction of palmar skin in
patients with neuropathy. During head-up tilt, the different palmar skin perfusion
responses between the two groups appears to indicate an abnormal function of
heat dissipation via opening AVAs in the neuropathy group. It is known that
palmar skin lacks active vasodilation (65). In our study, the absence of tiltinduced increase of skin perfusion of the palm in the neuropathy group
suggested a loss of tonic vasoconstriction at rest and an impaired ability to
increase blood flow by withdrawal of vasoconstriction of the palmar skin.
1.5.3 RR Interval Spectral Power Indexes of Sympathetic and
Parasympathetic Control of Heart Rate
The magnitude of the RR interval harmonic component at respiratory
frequencies (HFRRI) is a marker of vagal control of the SA-node (101). The rapid
decline of HFRRI in response to head-up tilt and rapid recovery of HFRRI when
AB subjects were returned to supine (within a minute of the change in posture,
Figure 1.8A) supports neural, reflex- mediated modulation of HR at respiratory
frequencies in these people. During supine rest and head-up tilt, diabetics with
definite neuropathy had lower HFRRI than did able-bodied subjects or diabetics
without neuropathy, indicating impaired parasympathetic control of HR in
diabetics with signs of peripheral neuropathy (124). The reduced reserve of
parasympathetic control of HR in response to head-up tilt in diabetics with
possible or definite neuropathy also confirmed a diminished orthostatic response
and progressive loss of parasympathetic control of heart rate with increasing
neuropathy (97).
A previous study of sino-aortic denervated (SAD) cats determined that the
wide band spectra of pulse interval was significantly lower in SAD cats than that
in controls (29). In our study, the decreases of wide band RR interval spectra in
diabetics with definite neuropathy may be due to diminished baroreflex function,
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or perhaps more specifically, to cardiac parasympathetic neuropathy. Moreover,
the LF RRI component was different in diabetics with definite neuropathy: a
steeper slope of the 1/f relationship was evident at the LF range of diabetics with
definite neuropathy. This 1/f relationship of power spectrum exists in dynamic
systems that have multiple control mechanisms with different time constants and
the steeper slope of the 1/f relationship suggests a less complex control system
(15, 16, 50, 133) in diabetics with definite neuropathy. If so, the complexity of the
sympathetic regulation of heart rate in diabetics with definite neuropathy was
diminished, possibly reflecting a diminution of sympathetic regulation of the SA
node, perhaps secondary to diabetic sympathetic neuropathy. In patients with
Chagas disease, which damages autonomic neurons, the slope of the linear part
of the log-log plot of PSD RRI was significantly steeper than that of controls,
indicating dysautonomia in these patients (27, 107). Therefore, the slope of loglog plot of heart rate power spectral density of resting diabetic subjects calculated
from a five-minute measurement appears to be a sensitive discriminator of
autonomic neuropathy in the LF region.
1.5.4 Blood Pressure Spectral Power Index of Sympathetic Control of
Peripheral Vasculature
Significant coherence between low frequency spectral power of diastolic
blood pressure (LFDBP) and muscle sympathetic nerve activity has been
reported in able-bodied humans (25). In particular, muscle sympathetic nerve
activity increased with head-up tilt and remained elevated during tilt in ablebodied subjects (46). In our study, LFDBP increased in response to tilt and
remained high in able-bodied and in diabetic subjects without neuropathy (Figure
1.8B). Conversely, in diabetics with possible, and those with definite, neuropathy,
LFDBP did not change indicating that reflex-mediated sympathetic pathways to
peripheral vasculature were impaired in diabetics, including those with milder
symptoms of neuropathy.
The log-log plot (Figure 1.9A, B) of the power spectral density of systolic
blood pressure (PSD SBP) taken during five minutes of supine rest, showed a
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significant elevation of harmonic and nonharmonic components of blood pressure
variability in the VLF and the HF regions but not in the LF range (presumably
because of a loss of the harmonic component) in diabetics with definite
neuropathy compared to able bodied subjects. These findings confirm the
previously reported reduction of sympathetically mediated harmonic vasomotion
in diabetic autonomic neuropathy (32, 144).
1.5.5 Dynamics of Skin Perfusion
The measured skin perfusion using laser Doppler technique is mainly from
capillaries and post-capillary venules of the upper horizontal plexus. These
vessels exhibit little variation in their diameter and thus have little contribution to
the rhythmic change in skin perfusion. Oscillations in skin perfusion are probably
related to constriction/dilation of upstream arterioles (23). The origin of the
vasomotion of skin blood flow was believed to be a combination of central/neural
and local/myogenic mediated mechanisms (119). The known impairment of
vasomotion of skin perfusion in diabetics was considered to be due to nerve
dysfunction, vascular abnormalities, or both (119). In the current study, the
comparison of the dynamics of skin perfusion between diabetics without and
those with neuropathy during supine control and head-up tilt in a thermoneutral
environment, allowed us to explore neural origins of skin perfusion oscillations
and effect of diabetic neuropathy on reflex control of skin perfusion under
orthostatic stress.
It was reported that passive change in posture increased the crosscorrelation between skin blood flow (volar surface of the forearm) and heart rate,
in which the maximum correlation during upright posture was always due to
oscillations in the range of 0.1 Hz (10). In the same study, sympathetic blockade
reduced the cross-correlation between skin blood flow and heart rate (10). Our
study support the influences of central autonomic control on skin blood circulation
via demonstrating significant coherence between skin perfusion of the forearm
and blood pressure in the LF region in subjects without neuropathy. The LF
coherence increased in response to tilt in the subjects without neuropathy, but
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decreased in those with neuropathy. This group difference indicated an impaired
central autonomic control of skin perfusion in diabetics with neuropathy.
In our study, the group difference in LF power spectral density of skin
perfusion of the forearm was not significant during supine control, but became
significant during head-up tilt, supporting the reduction of vasomotion in diabetic
patients with neuropathy (85). Bernardi et al reported that, when supine, there
was a significant difference in the LF skin blood flow oscillations in the forearm
between diabetic patients and able-bodied subjects, with the magnitude of
oscillations smaller in diabetics (11). However, in our study, the group difference
was significant during tilt but not during supine control, which may due to an age
difference between our able-bodied subjects and those in the study by Bernardi
et al (48 vs. 38 yrs), which had a known effect on the dynamics of skin perfusion
(11).
At the respiratory frequencies, the mean PSD of skin perfusion of the
forearm was greater in the neuropathy group than in the non-neuropathy group,
at supine control. It has been reported that respiratory oscillations is passively
transmitted from blood pressure to skin blood flow (9). In our study, the elevated
PSD of skin perfusion of forearm at respiratory frequencies in subjects with
neuropathy may be due to elevated blood pressure oscillations in these subjects.
Bernardi et al have reported that HF PSD of the skin perfusion of the forearm
was not different between diabetics and able-bodied subjects (11). This
discrepancy of HF PSD of skin perfusion between our and their studies may,
again, be due to a difference in age (~10 yrs older in our study) or breathing
patterns (spontaneous in our study vs. controlled breathing in that of Bernardi et
al). Controlled breathing may have effects on HF PSD of skin perfusion, since
controlled breathing reduced cardiac parasympathetic influences (102).
Similar to the skin blood flow of the forearm, in the palmar skin,
sympathetic nerve stimulation caused high-power peaks in the palmar skin blood
flow oscillations in healthy human, between 0.025 to 0.1 Hz, with the maximum
response within 0.075 - 0.1 Hz (120). In our study, the LF coherence between
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palmar skin perfusion and blood pressure became significant during head-up tilt
confirming a central sympathetic control of skin blood circulation (8, 9). In our
diabetics with neuropathy, the tilt-induced increase in LF coherence was not
observed, indicating an impaired central sympathetic control of peripheral
vasomotion. Significant LF coherences between skin blood flow (volar surface of
the finger) and blood pressure during supine was reported (8, 9). However, in our
study, the coherence between palmar skin perfusion and blood pressure at LF
was not significant during supine control in the non-neuropathy group. This may
due to the difference in the age of subjects (26 and 31 yrs in the previous studies
vs. 45 yrs in our able-bodied subjects and diabetics without neuropathy), or the
difference in the location of skin (finger vs. palm).
In our study, the mean LF power spectral density of palmar skin perfusion
in the non-neuropathy group did not increased in response to head-up tilt, in
contrast to the standing-induced increase in LF power of skin at fingertip in a
previous study (9). This discrepancy may due to the difference in the location of
the skin (fingertip vs. palm). The location of the measured skin may also explain
the absence of group difference in LF PSD of palmar skin perfusion during
supine control in our study, contrary to the reduction of oscillation below 0.1 Hz in
skin blood flow at pulpar surface of the index finger, in diabetics with neuropathy
(119).
Altered skin blood flow in diabetic patients could interfere with nutrient
supply, causing ulcers and gangrene (131). Our diabetic subjects did not
demonstrate these symptoms. However, autonomic regulation of skin perfusion
was impaired in these subjects. Manifestation of dysfunction in skin perfusion
regulation could occur earlier than symptoms of skin diseases in diabetic patients.
1.5.6 Baroreflex
The greater numbers of blood pressure ramps at rest and during tilt in
diabetics with definite and suspected autonomic neuropathy (Figure 1.18A), was
an unexpected finding of the present study. The combination of increased
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numbers of BP ramps with reduced numbers of baroreflex sequences (44, 144),
suggests that diabetics with neuropathy experience diminished effectiveness of
the baroreflex in driving the sinus node. As is clearly illustrated in Figure 1.18C:
BEI was significantly increased compared to supine control in able-bodied
subjects during all phases of head-up tilt and in diabetics without neuropathy
during 7-12 min of tilt, but remained unchanged in diabetics with possible, or
definite, neuropathy. Further, Figure 1.18 clearly illustrates the ability of this
measure to differentiate diabetics with neuropathy (definite or possible) from
diabetics without neuropathy. Therefore, in our study, BEI was the most sensitive
discriminator of neuropathy. Other studies have proposed LF power of SBP (32)
as a sensitive discriminator of AN, but for our study, BEI was significantly better
at discriminating differences, perhaps because this measure combines loss of
sympathetic modulation of vasomotion with loss of parasympathetic control of
heart rate into one parameter. Previous studies showed a severe impairment of
baroreflex effectiveness in diabetic chronic renal failure patients compared with
non-diabetic patients at supine rest (64). However, as far as we can determine,
the present study is the first to demonstrate a reduction in baroreflex
effectiveness in diabetics with neuropathy, without the simultaneous complication
of chronic renal failure.
Baroreflex sequences may reflect physiological activities in a portion of
these sequences. Baroreflex effectiveness index was 33% in intact cats and 4%
in sinoaortic denervated cats (31). Therefore, in cats, the number of sequences
due to physiological mechanisms was 29% of that of SBP ramps. Similarly, in our
study, BEI was 26% in healthy subjects, and 9.4% in diabetics with severe
neuropathy, during supine control. Therefore, in human, the number of
sequences due to physiological mechanisms was 16.6% of that of SBP ramps. In
addition, BEI increased in healthy subjects in response to head-up tilt, but did not
change in diabetics with neuropathy in our study. Therefore, baroreflex may be
engaged in a part of blood pressure regulation if it is measured by using the
baroreflex sequences technique. Baroreflex may be important in maintaining
homeostasis because the VLF and HF PSD of SBP were four fold higher, while
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the VLF, LF and HF PSD of RRI was four fold lower in diabetics with severe
neuropathy, compared to able-bodied subjects during supine control. Therefore,
BEI may reflect a fast response, while baroreflex is engaged at all frequencies.
Baroreflex sensitivity has been proposed to reflect the strength of the
baroreflex when it is effective (31). In our study, all groups demonstrated
decreased baroreflex slope in response to head-up tilt (Figure 5D) as expected
(67, 95, 96). However during both supine control and head-up tilt, diabetics with
definite neuropathy had significantly smaller BRS than did able-bodied subjects
and diabetics without neuropathy. During supine rest, diabetics without
neuropathy tended to have smaller BRS than able-bodied subjects and larger
BRS than diabetics with definite neuropathy. These findings support the widely
held notion that diabetes reduces BRS and that reduced BRS is an early sign of
AN (44, 104, 144). When we compared our significant reduction of BRS and BEI
to the trend towards greater arterial pulse transit time in diabetics with definite
neuropathy, we conclude that, for our study, baroreflex impairment was a more
sensitive indicator of neuropathy than alterations in arterial stiffness (110).
Increased BP variability has been shown to predict nephropathy and
retinopathy (71), and to correlate with endothelial and cardiovascular damage (28,
141) and higher mortality (70). Blood pressure variability, measured by standard
deviation over 24 h, has been reported to be significantly higher in diabetic
patients (43, 61, 87, 135) and was highest in those with cardiovascular
autonomic neuropathy (24). In our study, we further explored the specific
frequency ranges of increased BP variability and determined that diabetics with
definite neuropathy had significantly higher VLF and HF power spectral density of
SBP compared with able-bodied subjects. In addition, in all frequency ranges,
our able bodied subjects demonstrated an ability to engage heart rate to buffer
SBP fluctuations while diabetics with neuropathy demonstrated a reduced ability.
Arterial baroreflex buffering at respiratory frequencies may be more
dominant in older persons. The fact that HF power of SBP was greater in our
diabetics with neuropathy than in able-bodied subjects, but has been shown to
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be smaller in diabetic children and adolescents than in healthy controls (72), may
be a matter of age, but may, more accurately, reflect the presence of neuropathy
in our subjects. In addition, in middle-aged to older diabetics, HF power of SBP
was reported to be smaller than in able-bodied during conditions of controlled
breathing (32). The act of controlling breathing itself, however, may be
responsible for this effect since it was previously determined that controlled
breathing reduced cardiovascular parasympathetic influence (102).
An important indicator of impaired baroreflex-buffering of BP lies in the fourfold increase in the harmonic and nonharmonic components of VLF power
spectral density of SBP in diabetics with definite neuropathy compared with ablebodied subjects (Figure 1.9A, B). Although enhanced VLF SBP has been
reported to result from SAD in animals (19, 30), VLF SBP power in humans is
believed to reflect renin-angiotensin system activity, endothelial factors and
thermoregulation (101). However, in patients with primary autonomic failure,
enhanced VLF oscillations of SBP have been documented (97). Our study’s
enhanced VLF SBP power and decreased VLF RR interval power in diabetics
with definite neuropathy, indicated that intact baroreflex function is important for
normal BP regulation in the VLF range for both harmonic and nonharmonic
components in able-bodied humans. Finally, in our study, VLF SBP was similar
between able bodied and diabetics without neuropathy. This phenomenon has
been reported previously in children and adolescents with Type 1 diabetes
mellitus who have not developed other signs of neuropathy (72). These results
suggest that in addition to BEI, increased VLF SBP spectral power may be a
strong, early, indicator of diabetic neuropathy.
Our study did not show significantly increased standard deviation of SBP in
diabetics with neuropathy. Similar to the finding of Frattola et al.(44), this may be
due to the relatively short period of time over which the standard deviation was
calculated (3 - 5 min in our study and 15 min in the study by Frattola et al.)
compared to the greater standard deviation measured from 24h recordings (24,
43, 61, 87, 135).
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At frequencies centered around 0.1 Hz (Figure 4B), the log-log power
spectral density curve of SBP of diabetics with definite neuropathy demonstrated
a dip, indicating that the loss of the harmonic component at LF (Fig 3B) is
apparent in the log-log plot of SBP. This loss of power in the LF region is similar
to that previously reported following sino-aortic denervation in animals (29, 132)
and total autonomic failure in humans (97). Sympathetic nerve activity (SNA) with
a frequency around 0.1 Hz in man is similar to the 0.4 Hz rhythm in rat and, at
this frequency, there is a tight coherence in unanesthetized rat between changes
in SNA and changes in arterial BP (14). We conclude that the dip in oscillations
of SBP in the LF region of diabetics with definite neuropathy is consistent with
effects of neuropathy on sympathetically mediated vasomotion. This change is
exposed by the corresponding loss of parasympathetically (baroreflex) -driven
changes in heart rate in subjects with definite neuropathy. In addition, altered BP
and RR interval power spectral densities over the range of frequencies between
0.003 and 0.45 Hz in diabetics with neuropathy indicate that an intact baroreflex
is an important component of healthy human BP regulation at all frequencies.
Each of these measures is relatively easy to determine from a short (five minute)
recording of continuous blood pressure and heart rate from resting subjects.
1.5.7 Limitations
The time of onset, the prevalence and the development of diabetic
neuropathy, and treatment effects have been reported to be different between
Type 1 and Type 2 diabetes (130, 142). Because of our limited number of
subjects, diabetic patients were not separated based on the type of diabetes.
Therefore the relative ability of our indices of autonomic dysfunction to identify
autonomic neuropathy in Type 1 vs. Type 2 diabetes is unknown. Direct
measures of sympathetic autonomic function (like MIBG SPECT imaging) were
not performed, thus comparisons between direct measures and our indices are
not available. Again, because of the limited numbers of subjects in each group,
we were not able to establish age effects on the autonomic indices we report.
The D0 group was younger than the D2 group; however, major differences in this
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study lay between AB and D2 groups where there was no meaningful difference
in age. Greater numbers of subjects would be required to establish significant
interactions of study variables with gender and age.
The rate of presyncope (5 of 11) in the able-bodied subjects of the present
study was similar to the able-bodied subjects that have reported by our lab in the
past (78). In that study, 8 of 16 controls had symptoms within 30 minutes of
head-up tilt. In another recent study of subjects who underwent 70-degree headup tilt, 56% (9 of 16) had presyncopal symptoms during the 30 min tilt (36).
Results from a third study of head-up tilt-mediated presyncope in healthy humans
suggested that unexplained syncope was a result of altered cardiorespiratory
interaction involving cerebral hemodynamics but with a normal neural control
system (73). Similar to our results, other investigators have determined that the
initial response to head-up tilt was similar between patients with vasovagal
syncope and nonsyncopal subjects, and sympathetic nerve activity withdrawal
did not occur until symptoms began (88). We do not believe that the incidence of
presyncopal events in the AB subjects is remarkable, nor does it call into
question any aspect of the interpretation of our findings.
Finally, abnormal findings in the battery of Ewing tests have been reported in
13% of the normal population (99). In our study, two able-bodied subjects with
tingling of hands and/or feet were found to be free of peripheral neuropathy by
standard clinical tests. Both subjects, however, decreased their BEI to near 0% in
response to tilt while other able-bodied subjects increased or maintained their
BEI at greater than 10%. In the group of diabetics with definite neuropathy, 6 of
8 subjects had BEI smaller than 10%. The similar behavior of the two ablebodied subjects to the behavior of the six diabetics with definite peripheral
neuropathy suggests that BEI during tilt may be an index of autonomic
neuropathy that is more sensitive, and/or more selective for autonomic
involvement than are standard sensory/motor neuropathy findings. Also for other
variables, when we removed these two subjects from the able-bodied group, the
statistical significance of the group differences reported here were dramatically
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increased, but without a physiological reason to remove them, the results
reported here include these subjects with the able-bodied group.
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1.6 Chapter Six: Conclusions
The much reduced ability to regulate blood pressure, characterized by
decreased RRI buffering of an increased number of SBP ramps, the four-fold
increases in VLF and HF SBP power spectral densities and the four-fold
decrease in VLF, LF and HF RR interval power spectral densities indicated
serious deficits in maintenance of cardiovascular homeostasis in diabetics with
neuropathy. The major contributor to this loss of blood pressure regulation
appeared to be the combination of a loss of sympathetically mediated control of
vasomotion, with a reduced contribution from parasympathetically mediated
responses of heart rate to buffer these changes in blood pressure. Our results
indicate that preservation of baroreflex function needs to become a focus of
diabetic neuropathy treatment. The present study also indicates that, in healthy
subjects, baroreflex function is an important component of blood pressure
regulation in all (very low, low and high) frequency regions and pertains to both
self-similar as well as harmonic components. In addition, sympathetic control of
skin perfusion was impaired in diabetic patients with neuropathy, which
manifested earlier than signs of skin diseases. Finally, the results of our study
indicate that noninvasive indexes of autonomic regulation were able to
discriminate diabetics with autonomic neuropathy from subjects with reduced, or
no, neuropathic damage.
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1.7 Chapter Seven: Future Work
The measurement of plasma volume and hormone levels from blood
samples, as well as stroke volume from bio-impedance will give further indication
of blood pressure regulation by fluid shift, hormones and cardiac function. In
addition, phase analysis of the time relationship between oscillations of skin
perfusion and blood pressure will provide further information on mechanisms of
reflex control of skin blood flow. These data are available for analysis and
therefore will be included in the next manuscript which will be focused on group
differences in distribution of blood flow and hormonal responses during the
orthostatic stress.
In order to compare our noninvasive indexes with standard tests,
comparisons to Ewing tests and MIBG-SPECT image need to be made to
correlate these indexes with current clinical diagnoses of autonomic neuropathy
and the gold standard method of detection of autonomic neuropathy to the
myocardium. These comparisons have been, and will be, the topic of proposals
submitted to extramural funding agencies.
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Part 2.

Four-dimensional multiscale model of ECG

indexes of diabetics with autonomic neuropathy
2.1 Chapter One: Introduction
Prolongation of heart-rate corrected QT (QTc) interval of the ECG is well
known in diabetic patients with autonomic neuropathy, and is correlated with the
extent of autonomic neuropathy (51, 69, 83, 100, 125). Prolongation of QTc is
associated with the risk of dying unexpectedly in diabetic patients with autonomic
neuropathy (38) , and predicts long-term cardiac death in patients with noninsulin dependent diabetes mellitus (17, 81, 90, 106), and insulin dependent
diabetes mellitus (108, 127). However, the mechanism of QTc prolongation in
diabetic patients with autonomic neuropathy is still unknown. QTc interval
prolongation does reflect an alteration of myocardial repolarization (137). Direct
comparison of maximal QTc interval and global or visual defects in patterns of
myocardial MIBG uptake in diabetic patients demonstrated a relationship
between QTc interval and regional cardiac sympathetic denervation (74). The
aims of this part of the study are to 1) verify that the QT interval prolongation in
our diabetic patients were similar to the prolongation reported in previous studies
and 2) link QT interval prolongation to regional cardiac sympathetic denervation,
at the cellular level using a computer heart-torso model.
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2.2 Chapter Two: Background
2.2.1 Cellular Basis of Autonomic Control of Ventricular Repolarization
Sympathetic stimulation increases the contractility and rate of relaxation of
the heart (79). In normal heart ventricles, postganglionic sympathetic fibers
release the neurotransmitter norepinephrine which binds to β-adrenergic receptor
on the cell membrane of myocytes. One subtype of β-adrenergic receptor, the
β1-receptor dominates in ventricular myocytes (79). β1-receptor stimulation
activates the cAMP-dependent PKA pathway, resulting in an increase in L-type
calcium current through Cav1.2 channels and a faster rate of closure of the
channels through negative feedback (145). In addition, β1-receptor stimulation
augments potassium current through the slowly activating, delayed-rectifier,
potassium channel. This activation results in the shortening of cardiac action
potential in order to maintain adequate diastolic filling between beats, in the face
of an increase in heart rate that occurs upon sympathetic nerve stimulation (145).
Finally, sympathetic signaling modulates the rapidly activating, delayed-rectifier,
potassium channel in a highly complex manner, resulting in opposite effects on
current amplitude (145).
Sympathetic denervation by β-blockers exerts opposite effects on
repolarization of cardiac myocytes. For example, administration of β-blockers
such as atenolol and sotalol caused action potential duration (APD) prolongation
(66, 103), while esmolol caused APD shortening by inhibiting L-type calcium
current (40). Similarly, sympathetic denervation by stellate ganglionectomy
(dogs) or phenol (rabbits) resulted in prolongation of repolarization (139, 140) ,
while bilateral sympathetic ganglionegtomy resulted in shortening of APD in a
study of rats (136).
2.2.2 Autonomic Innervation of Ventricles
Sympathetic stimulation improves synchrony of excitation and contraction
(3). Stimulation of individual cardiac nerve induces highly localized and
differential changes in automatic, conductile and contractile function (3). For
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example, right stellate ganglionectomy in dogs resulted in larger prolongation of
functional refractory period at the anterior surface of the heart than at the
posterior surface, while additional left stellate ganglionectomy resulted in larger
prolongation of functional refractory period at the posterior surface than at the
anterior surface (139). In addition, a single sympathetic nerve modulates finer
myocardial segment. For example, electrical excitation of distal ventrolateral
cardiac nerve induces increased contraction of posterior papillary muscle without
noticeable alteration in the anterior papillary muscle of the same ventricle (3);
comparable stimulation of ventromedial cardiac nerve increases anterior papillary
muscle contraction without affecting the posterior muscle (3).
Distribution of sympathetic nerves in epicardium, endocardium and
midmyocardium of animal heart has been reported (26). Percentage stained area
of tyrosine hydroxylase- and neuropeptide Y-immunoreactive nerves
(sympathetic nerves) are largest in epicardium, smaller in endocardium and
smallest in midmyocardium (26).
2.2.3 Cardiac Autonomic Dysfunction in Diabetes
Direct measure of cardiac sympathetic innervation can be performed by
MIBG-SPECT and HED-PET imaging (54, 63). The measures of cardiac
autonomic neuropathy by MIBG-SPECT and HED-PET (122) have revealed
inhomogeneous sympathetic innvervation of the left ventricle in diabetic patients
(22, 56, 91, 92, 113-116). Low uptake of tracer has been observed in the
posterior, inferior, or dorso-septal areas of the left ventricle in diabetic patients.
The region with low uptake of MIBG extended to other areas in patients with
autonomic neuropathy. A recent study, using MIBG-SPECT imaging, showed
that in patients with innervation defects, 46% of the innervation defects were
located at the inferior region, 18% were located at more than one region, 16%
showed diffuse diminished uptake, 14% were located at the apex and 6% were
located at the anterior region (115). Proximal hyperinnervation complicating distal
denervation in diabetic patients with normal myocardial perfusion has also been
reported (123).
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2.2.4 Previous Simulation Studies
The forward problem and inverse problem of electrocardiography have
been the focus of simulation studies attempting to locate the site of abnormal
electrical activity of the heart in patients with myocardial infarction (41), WolffParkinson-White syndrome (48), long-QT syndrome (68) and bundle branch
block (2). The forward problem estimates the body surface potential from an
equivalent source of cardiac electrical activity while the inverse problem
approximates the electrical properties of the heart from measured body surface
potential (53). The relationship between increases in QTc interval and the extent
of diabetic autonomic neuropathy, diagnosed by clinical methods, implies that the
change in ventricular repolarization of myocardium may be a result of alterations
in cardiac innervation. To our knowledge, this study is the first to describe
possible mechanisms of QTc interval prolongation in diabetics with autonomic
neuropathy by using a priori changes in membrane potentials at the cellular level
directly to predict changes in body surface potentials. This study aims to link the
QT interval prolongation observed in diabetic patients with autonomic neuropathy
to the patterns of regional cardiac sympathetic denervation.
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2.3 Chapter Three: Methods
2.3.1 Experimental Study
2.3.1.1 Subjects
The subjects of this part of study were the same as in Part 1, which
consisted of 12 able-bodied subjects, 7 diabetics without neuropathy, 7 with mild
neuropathy and 8 with severe neuropathy.
2.3.1.2 Data acquisition
Twelve-lead ECG was acquired from supine subjects breathing at15
breaths/min. Data acquisition of 12-lead ECG lasted for approximately 5 min or
until at least 256 heart beats were recorded for signal averaging.
2.3.1.3 Signal Preprocessing
Before performing QT interval measurement, ECG signals were
processed to remove baseline wander (< 1Hz), power line noise (~60 Hz) and
muscle noise for accurate characteristic wave detection (1). Baseline wander and
power line noise were removed by two digital filters, a highpass and a lowpass
filter, designed to meet American Heart Association (AHA) recommendations for
minimizing distortion: amplitude response should be flat to within 6% (0.5 dB)
over a range of 1.0-30 Hz; the 3 dB points should be less than or equal to 0.67
Hz (6). A butterworth filter is known to have a flat response at pass band and was
therefore applied in this study. The MATLAB command ‘buttord’ was used to
determine the order and cutoff frequency with these specifications. A highpass
filter with 3 dB point at 0.67 Hz, and 60 dB point at 0.025 Hz, required a minimum
order of 3, rendering the response at 1 Hz to be -0.38 dB. A lowpass filter with 3
dB point of 40 Hz, and 60 dB point of 250 Hz, required a minimum order of 4,
rendering the response at 30 Hz to be -0.41dB. Then, filter coefficients were
generated by using the MATLAB command ‘butter’, and signals were filtered
forward and then backward to give a response with zero phase shift, by using the
MATLAB command ‘filtfilt’.
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After filtering, ECG waveforms of multiple beats were coherently averaged
to remove muscle noise in the signal and improve signal-to-noise ratio (1, 76).
Before averaging, the R peak of each beat was determined by setting a
magnitude threshold manually, from which RR intervals (RRI) were calculated.
Only beats having an RRI with the difference from the mean RRI less than 10%,
were accepted for averaging (76). Segments which started 400 msec before the
R peak and ended at the end of the P wave of the next beat (accepted beats)
were aligned at the R peak, summed point by point, and then divided by the
number of beats. QT interval was measured from the averaged waveform in each
lead.
2.3.1.4 QT Interval Measurement
QT interval was measured by observing the signal and clicking in the
graph of the signal at the Q wave onset and T wave end (Figure 2.1). The
measurement was done without knowing the classification of subjects. The Q
wave beginning was determined at the first deflection from baseline after the P
wave. The T wave end was determined at the time when the signal went back to
the TP baseline. If the T wave went asymptotically to the baseline, then the T
wave end was determined as the intercept of the slope of the fastest decreasing
segment of the T wave and the TP baseline. If a T wave was followed by a U
wave, the T wave end was taken as the nadir between the T wave and the U
wave. Merging of T wave with U/P wave, low T wave amplitude and various T
wave morphologies have been reported to cause measurement error (82). If any
of these features was present, the measurement was abandoned for that lead.
Seventeen subjects had 1~3 leads abandoned. QT interval was not measured for
one subject because of the presence of these features in most leads. QT interval
was averaged from three measurements at different times. The heart rate
corrected QT interval (QTc) was computed with Bazett’s equation
𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑄𝑇 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 (𝑄𝑇𝑐) =
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𝑄𝑇 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙

√ 𝑅𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙

Maximum and minimum QTc of all leads were determined from the 12 leads.
Minimum QTc of inferior leads (leads II, III and aVF), septal leads (leads V1 and
V2), anterior leads (leads V3 and V4) and lateral leads (leads I, aVL, V5 and V6)
were also determined (94).
Averages of ECG Complexes
Number of averaged beats: 268 (Total: 269)
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Figure 2.1 Typical averaged ECG complexes and manual QT interval
measurement.
2.3.2 Simulation Study
2.3.2.1 Structure of Ventricles
The geometry of the ventricles was constructed by forming 90 crosssections along planes perpendicular to the base to apex axis. Each cross-section
contained a ring with 9 concentric circles with different radiuses, constructing the
transmural layers of left ventricle, and 3 concentric partial circles with different
radiuses, constructing the transmural layers of right ventricle. This was done by
the following steps:
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1) Construct a 90mm*60mm*90mm cubic consisting of a rectangular grid of
discrete points with 1mm distance between points.
2) Determine the centers of the circles of left ventricle at all cross-sections, which
was a vertically straight line consisting of points with the same x and y
coordinates at all cross-sections.
3) Determine the radiuses of the circles of the left ventricle of all cross-sections,
which was determined by an ellipse equation representing the curved shape of
the ventricular walls.
4) Recruit elements in the cubic, one cross-section by one cross-section, and
one transmural layer by one transmural layer, with every transmural layer
determined by their distances to the center of the circles. An ID of the transmural
layer was assigned to every element ranging from 1 to 9 (Figure 2.2).
5) Determine the centers of partial circles of right ventricles as points along the
right side of the septum. Because the centers of right ventricle formed a curve,
the lateral wall of right ventricle was more curved than that of the left ventricle.
6) Determine the radiuses of the partial circles of the right ventricle, one crosssection by one cross-section, which decreased from base to apex, according to
an ellipse equation.
7) Recruit the elements in the cubic to form the right ventricle, one cross-section
by one cross-section, and one transmural layer by one transmural layer, with
every transmural layer determined by their distances to the center of the partial
circles, which are equal to the radiuses. An ID of each transmural layer was
assigned to every elements ranging from 1 to 3 (Figure 2.2).
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Figure 2.2 Transmural layers of left and right ventricles, from endocardium
to epicardium.
8) In addition to the ID of transmural layers, the ID of endo-, mid- or epimyocardium was also assigned (Figure 2.3).

Figure 2.3 Determination of endocardium (orange), midmyocardium (green)
and epicardium (blue).
9) A region ID was also assigned to every element (Figure 2.4). The regions
were divided according to the polar map of the left ventricle in MIBG-SPECT
imaging (55): apical, distal/basal anterior, distal/basal inferior, distal/basal septal
and distal/basal lateral regions.
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Figure 2.4 Division of the regions of left ventricle (3D view, left; top view,
right).

These resulted in a three-dimensional array of 129,826 points
representing the ventricles of the heart. The construction of the model and
following simulations were performed in MATLAB.
2.3.2.2 Normal Electrical Activity of Heart – Activation Sequence
Production of Normal Activation. Clinical endocardial excitation map of
human left ventricle showed that the site with the earliest excitation of the left
ventricle was located in an area between the middle and anterior septum near
the apex (personal communication with Dr. Morales). Therefore, at the left side of
the septum, one point between middle and anterior area near the apex was
assigned with the earliest activation time (Figure 2.5). In the right ventricle, two
points at the free wall and the septum near the apex were assigned an activation
time 5 msec later than that of the left ventricle, as indicated by the activation
sequence of an isolated human heart (33).
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Figure 2.5 Production of normal electrical activities of left and right
ventricles (3D view, top; front view, bottom left; top view, bottom right).

Electrical Excitation Propagations to Six Nearest Neighbors. When one
element was activated, the excitation propagated to its six nearest neighbors at
the next time step or in the next few time steps, according to the conduction
velocity. With 1mm distance between elements and the largest conduction
velocity of 4 m/s, the smallest time step was set to be 0.25 msec. The activation
propagation to neighbors was delayed in regions with a slower conduction
velocity. The transmural velocity ranged from 0.222 m/s to 0.45 m/s (33). The
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slowest transmural velocity speed was at the septum, and the transmural velocity
increased gradually from 0.25 m/s, at the apex, to 0.45 m/s, at the base of the
free walls. This difference in velocity was adopted from the excitation isochrone
of the isolated human heart, in which transmural velocity was slower in the area
where excitation occurred earlier (33). Therefore, in this model, the transmural
velocity described above was assigned to make the earlier excitation area have
slower transmural velocity. Faster conduction velocities were assigned to
endocardia to simulate the Purkinje network. As shown in Figure 2.6, the
endocardia had a fast conduction velocity 4 m/s in a fan pattern, and other
endocardia between the lines of the fan had conduction velocity of 2 m/s. This
arrangement of conduction velocity between endocardial cells led the
propagation of excitation from apex to base.

Figure 2.6 Propagation speed of electrical activation to six neighbors (3D
view, left; top view, right).
The resultant activation sequence is shown at a series of horizontal crosssections, a middle-front cross-section (Figure 2.7), endocardial layers and
epicardial layers (Figure 2.8).

63

Figure 2.7 Activation sequence at horizontal cross-sections (left) and
middle frontal cross-section (right).

Figure 2.8 Activation map of endocardium (left) and epicardium (right).
2.3.2.3 Normal Electrical Activity of Heart – Repolarization
Distribution of Action Potential Duration (APD). The length of APD was
different in the three types of myocardium: midmyocardium longest, endocardium
shorter and epicardium shortest (138). The APDs increased gradually from
endocardium to midmyocardium, and decreased sharply from subepicardium to
64

epicardium transmurally (138). In addition, APDs at the apex were slightly longer
than those at the base (118). In the septum, APDs progressively lengthened from
right ventricular to left ventricular endocardium (89). In this model, the normal
APD distribution had a transmural gradient and an apex-to-base gradient. At the
apex, APDs of the elements from epicardium layer to endocardium layer at the
free wall of the left ventricle were 216, 222, 246, 252, 258, 264, 270, 264, 258
msec, at the septum were 224, 227, 230, 233, 236, 239, 242, 245, 248 msec,
and at the free wall of right ventricle were 206, 230 and 224 msec. The APD
decreased gradually from apex to base, so that APDs were 10 msec shorter at
the base than those at the apex. The distribution of APD is shown in Figure 2.9.

Figure 2.9 Distribution of action potential durations (3D view, top; middle
horizontal cross section, bottom left; middle front cross section, bottom
right).
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Cellular Action Potential Model. The intracellular action potential model
consisted of a step change from resting potential -90 mV to 10 mV simulating
depolarization, followed by six linear lines changing from 10 mV to -90 mV
simulating repolarization. Similar to a previous study (86), the differences of APD
were accomplished by proportionally changing the lengths of the first two lines of
repolarization (Figure 2.10). In the abnormal model, the prolongation or
shortening of APD was accomplished by proportionally prolonging or shortening
the lengths of the first two lines of repolarization.

Figure 2.10 Model of intracellular action potential with different durations.
2.3.2.4 Heart-Torso Model
Position of Heart in Torso. The torso was modeled as an homogeneous
volume conductor. The torso has a cylinder shape with maximum length 300 mm
from left to right, maximum length 200 mm from front to back and 350 mm from
top to bottom (Figure 2.11). The heart model, located inside the torso model, was
surrounded by the point elements on the torso surface. The position of the heart
inside the torso was determined by first setting the center of the heart model the
same with that of the torso model except 50 mm higher than the torso model.
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This resulted in the anterior side of both ventricles facing the front side of the
torso model. Then the heart model was rotated by 45 deg along the longitudinal
axis of the torso and then 45 deg along the mediolateral axis of the heart model.
After the rotations, the heart model was displaced to the left side of the torso by
90 mm and the front side by 45 mm. This resulted in the heart model being closer
to the left and front side of the torso model and the apex pointing towards the left
down side. The locations of the electrodes of 12-lead ECG were determined on
the body surface according to the standard placement.

Figure 2.11 Views of heart inside torso, heart rotation and positions of
electrodes (3D view, top left; lateral view from left, top right; top view,
bottom left; front view, bottom right).
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Body surface potential: solution of forward problem. The computation of
surface potentials was similar to that of Miller et al. (86) except that this study
calculated the current dipole at each point of the heart model, instead of dividing
the heart model into 23 regions. Considering a three dimensionally distributed
myocardia network, if the gradient of the intracellular potential exists, there will be
a current flow from high intracellular potential to low intracellular potential as
𝐽𝑖̅ = −𝜎𝑖 ∇∅𝑖

where 𝐽𝑖̅ is intracellular current density, 𝜎𝑖 is the effective conductance of

intracellular network (set to equal to 1 in the model) and ∅𝑖 is the intracellular
potential.

In this model, the individual myocardial segments were discrete points in a
rectangular grid, therefore the gradient function at one point can be approximated
as the potential differences of it six neighbors as
∆∅𝑙,𝑚,𝑛 =

∅𝑙+1,𝑚,𝑛 − ∅𝑙−1,𝑚,𝑛
∅𝑙,𝑚+1,𝑛 − ∅𝑙,𝑚−1,𝑛
∅𝑙,𝑚,𝑛+1 − ∅𝑙,𝑚,𝑛−1
𝑙̅ +
𝑚
�+
𝑛�
2∆𝑙
2∆𝑚
2∆𝑛

where ∅𝑙,𝑚,𝑛 is the intracellular potential at point 𝑙, 𝑚, 𝑛 in the three dimensional

grid, ∆𝑙 is the distance between two points and 𝑙 ̅ is the unit vector along the 𝑙 axis.

The directions of the unit vectors are shown in Figure 2.12. The unit vectors were
fixed three-element arrays acquired by scaling the length of the three vectors.
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Figure 2.12 Directions of unit vectors of the heart coordinates along the
dimension of the cell grid in the directions of the l, m and n axes (green,
red and purple lines).
The volume integral of the current density 𝐽𝑖̅ at the small space around a

point can be approximated as following and is equivalent to a current dipole (105)
𝑃�𝑙,𝑚,𝑛 = −𝜎𝑖 (∇∅𝑙,𝑚,𝑛 )𝑑𝑙 𝑑𝑚 𝑑𝑛

The simulation sources are thus a set of 129,826 time-varying current dipoles.
The electrical field of one observation point on the body surface (xp, yp, zp) can
be calculated as follows

Φ( x p , y p , z p ) =

1
1
Pl ,m ,n • ∇ dxdydz =
∫
4πε 0
4πε 0 volume
r
1

∫

volume

Pl ,m ,n • u x , y , z , x p , y p , z p
r 2 x, y,z ,x p , y p ,z p

dxdydz

where 𝑢�𝑥,𝑦,𝑧,𝑥𝑝 ,𝑦𝑝 ,𝑧𝑝 is a three-element array, representing the unit vector pointing
from an element at (x, y, z) of the heart model towards an electrode on the body
surface at (xp, yp, zp). r is the distance between the element at (x, y, z) of the
heart model and the electrode on the body surface at (xp, yp, zp). ε0 is the
permittivity of free space. In the model, the permittivity was set to be 1 according
to the assumption that the torso was an homogenous conductor.
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Twelve-lead ECG is calculated from the 9 body surface potentials at the
locations of the electrodes RA, LA, LL, V1, V2, V3, V4, V5 and V6 as the
following:
1) limb leads

I = LA − RA
II = LL − RA
III = LL − LA
2) augmented limb leads
1
aVR = RA − ( LA + LL)
2
1
aVL = LA − ( RA + LL)
2
1
aVF = LL − ( RA + LA)
2

3) precordial leads
1
VW = ( RA + LA + LL)
3
V1 = V 1 − VW , V2 = V 2 − VW
V3 = V 3 − VW , V4 = V 4 − VW
V5 = V 5 − VW , V6 = V 6 − VW

where VW is the Wilson's central terminal used as the negative electrode for the
precordial leads.
QT interval measurement of modeled ECG. The T wave end of modeled
ECG was determined by using a voltage threshold method. The peak of the T
wave was identified at the time when the ECG arrived at its maximum absolute
value after the QRS complex. The end of the T wave was identified when the
absolute voltage of the T wave decreased to ten percent of the voltage of the T
peak (Figure 2.13). The QT interval was computed as the time difference
between first activation and the T wave end.
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Figure 2.13 Twelve-lead ECG generated from normal model and the
detection of the T peak and the T wave end.
Regional dipoles and 12-lead ECG. The activities of the heart model with
all parts integrated are shown in the movie ‘Heart Model and ECG.wmv’. Dipoles
were estimated at every cell element as a source of the electrical field of the
extracellular space, which were proportional to the differences of the intracullular
potentials of its six neighbors. In order to visualize the contribution of the dipoles
of all regions, the dipoles of one region were averaged and ploted as a green
quiver located at the average of the coordinates of the cell elements in that
region. The direction of the quiver corresponds to the direction pointing from the
negative charge to the positive charge of the dipole. In order to visualize the
major force of the heart model, which is reflective of the general morphology of
the ECG, the average dipole of all cell elements of the heart was plotted as a red
quiver located at the average of the coordinates of all cell elements. The
intracellular potentials and dipoles changed with time during the processes of
depolarization and repolarization of the heart, generating the QRS complex and
T wave in ECG (see movie).
2.3.2.5 Diabetes Effects on Normal Heart
Prolongation and Shortening of Action Potential. In two previous animal
studies, cardiac sympathetic denervation by stellate ganglionectomy or phenol
resulted in prolongation of the functional refractory period (139) or activation71

recovery interval (140), while in another animal study, cardiac sympathetic
denervation by bilateral sympathetic ganglionegtomy resulted in shortening of the
APD (136). In this study, both prolongation and shortening of the action potential
were simulated.
Transmural differences of APD changes. It has been shown that the
stained area of tyrosin hydroxylase- and NPY- immunoreactive nerves
(sympathetic nerves) was largest in epicardium followed by endocardium, and
was smallest in midmyocardium in pig heart (26). The ratio of the stained areas
was approximately 5:3:1 in epicardium, endocardium and midmyocardium,
respectively (26). In this study, APD changes applied in epicardium, endocardium
and midmyocardium in the heart model were set accordingly with this ratio.
Regions in the heart model being affected. Four patterns of abnormal
cardiac sympathetic innervation have been reported in studies of diabetic cardiac
autonomic neuropathy, shown by MIBG-SPECT or HED-PET images: 1) low
tracer uptake in one region, 2) low tracer uptake in more than one region, 3)
reduced uptake in the whole heart, and 4) denervation in distal regions
complicated by hyperinnervation in basal regions. In the heart model, regions of
the left ventricular walls and septum were divided according to the polar map,
which was used previously in a MIBG-SPECT study (55). Hyperinnervation was
simulated by applying the opposite APD changes of denervation. Figure 2.14 and
Figure 2.15 show examples of prolonging and shortening of APD at one region,
the basal anterior region.
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Figure 2.14 Example of simulation of possible effects of diabetic
neuropathy to the heart: prolongation of APD at basal anterior region.
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Figure 2.15 Example of simulation of possible effects of diabetic
neuropathy to the heart: shortening of APD at basal anterior region.
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Matching procedure. In order to link clinically observed QT interval
changes, to cardiac sympathetic denervation or hyperinnervation seen in cardiac
imaging studies, the following procedure was followed:
1) In experimental ECG, QT interval changes in diabetic patients with neuropathy,
compared to those of able-bodied subjects were characterized.
2) In the model, simulations of abnormal heart with different patterns of cardiac
sympathetic denervation or hyperinnervation were performed.
3) Within the results of simulation, the pattern that generated 12-lead ECG and
QT intervals which best matched the characteristics of experimental QT intervals
of diabetics with neuropathy was chosen as an inverse solution.
4) In the model, abnormal patterns were further modified to determine whether
the characteristics of experimental QT intervals could be better matched.

2.4 Chapter Four: Results
2.4.1 Experimental ECG
Group mean RR intervals of supine able-bodied subjects, diabetics
without neuropathy, diabetics with mild neuropathy and diabetics with severe
neuropathy are shown in Figure 2.16. RR interval tended to be different among
groups (p=0.0829, ANOVA).

Figure 2.16 Five-minute, resting, average ± SEM RR interval of able-bodied
subjects (AB), diabetics without neuropathy (D0), diabetics with mild
neuropathy (D1) and diabetics with severe neuropathy (D2).
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Group mean QT intervals and heart rate-corrected QT interval (QTc) of 12
leads are shown in Figure 2.17. QT intervals of able-bodied subjects did not differ
from those of diabetics with severe neuropathy. QTc of able-bodied subjects
tended to be shorter than diabetics with severe neuropathy (p=0.051 for lead aVL,
p=0.104 for lead I, using two-tail t test between able-bodied subjects and
diabetics with severe neuropathy). QTc intervals of diabetics without neuropathy
tended to be the longest in the four groups.

Figure 2.17 Average ± SEM QT interval (top) and heart rate-corrected QT
interval (QTc, bottom) of 12-lead ECG of four groups.
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Maximum and minimum QTc of all leads measured over supine control
period are shown in Figure 2.18. Maximum QTc was not different between ablebodied subjects and diabetics with severe neuropathy. Minimum QTc was not
different between able-bodied subjects and diabetics with severe neuropathy, but
demonstrated a tendency to be different.
Max QTc, All Leads
p = 0.44 AB vs. D2

Min QTc, All Leads
p = 0.16 AB vs. D2
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D1
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D0
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Figure 2.18 Individual maximum QTc (left) and minimum QTc (right) of all
leads in the four groups.

Minimum QTc of septal leads, anterior leads, lateral leads and inferior
leads for all subjects are shown in Figure 2.19. Minimum QTc of lateral leads
tended to be different between able-bodied subjects and diabetics with severe
neuropathy (p = 0.095, two-tail t test between able-bodied subjects and diabetics
with severe neuropathy).
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Figure 2.19 Individual minimum QTc of septal leads (top left), anterior leads
(top right), lateral leads (bottom left) and inferior leads (bottom right) of the
four groups.

Two characteristics were identified in QTc interval to be matched by the
model. First, diabetics with severe neuropathy tended to have longer QTc interval
in all leads than did able-bodied subjects. Second, minimum QTc interval from
lateral leads demonstrated greater group difference between able-bodied
subjects and diabetics with severe neuropathy when compared to other leads. In
addition, a third characteristic of ECG, morphology, needed to be matched.
Specifically, the T waves of lateral leads V5 and V6 should be positive which was
observed in the ECG of all subjects.
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2.4.2 Modeled ECG – Normal Model
QT intervals of 12-lead ECG from the model of the normal heart are
shown in Figure 2.20. Compared to the QTc interval of 12-lead ECG from ablebodied subjects, there was a similar dip at lead V2. The lack of a dip at aVL in
the model, compared to the able-bodied subjects, did not appear to be an
important factor in model function, perhaps due to the anatomy of the model vs.
real heart. In the subsequent simulation of abnormal heart, changes from normal
QT intervals were computed.

Figure 2.20 QT interval of 12 leads generated from normal model.

2.4.3 Modeled ECG - Diabetic Effect on Normal Model
Determination of the amount of APD changes in simulation. In order to
determine the amount of APD changes, the effects of changing APD on 12-lead
ECG and QT interval were assessed, by prolonging and shortening APD to
different extent at one region (Figure 2.21, Figure 2.22). The shape of ECG
showed that shortening APD at one region, for example, in the distal inferior
region, primarily modified the ST segment and the ascending part of the T wave
(blue lines in Figure 2.21). Conversely, prolonging APD in the distal inferior
region primarily modifed the descending part of the T wave (red lines in Figure
2.21). Greater APD prolongation generated greater changes in QT interval
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(Figure 2.22). In subsequent simulations, a 60 msec change in epicardial APD,
36 msec endocardial and 12 msec midmyocardial generated changes of QT
interval by the desired amount of 20 msec, as observed in the QTc interval of
lateral leads. Some exceptions occurred; 1) at the septum, 36 msec change was
applied at both sides of the endocardium; 2) to simulate diffuse reduction of
innervation, 20 msec change in APD at the epicardium, 12 msec at the
endocardium and 4 msec at the midmyocardium were applied to the whole
septem and left ventricular walls, in order to correspond to the definition of diffuse
uptake of MIBG observed in a previous study that reported reduced global heartto-mediastinum ratio without obvious regional defect in SPECT polar map (115).
Although shortening APD in the distal inferior region did not produced QT interval
prolongation in most leads, as did prolonging APD (Figure 2.22), it did prolong
QT interval in several leads. Therefore, both prolonged and shortened APD were
applied, respectively.

Figure 2.21 Twelve-lead ECG of normal model and abnormal models by
prolonging or shortening APD to different extent in the distal inferior region.
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QT Interval
Effects of Prolonging or Shortening APD to Different Extents in
the Distal Inferior Region
300
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Figure 2.22 QT interval of 12 leads of normal model and abnormal models
by prolonging or shortening APD in the distal inferior region, when
applying different magnitudes of APD changes.

QT interval from simulation of regional abnormalities of cardiac
sympathetic innervation. Action potential durations were prolonged or shortened
by 60 msec at the epicardium, 36 msec at the endocardium and 12 msec at the
midmyocardium in the following single regions respectively: distal inferior, basal
inferior, distal lateral, basal lateral, distal anterior, basal anterior, distal septal,
basal septal regions and apex. QT intervals were computed in every trial. QT
interval changes due to prolonging APD at these regions are shown in Figure
2.23. QT interval changes due to shortening APD at these regions are shown in
Figure 2.24. The patterns that prolonged APD in the distal lateral or basal septal
regions were selected because these modifications generated increases in QT
intervals of all leads.

81

Delta of QT, msec

Delta of QT from Normal
Effects of prolonging APD in one region
60
40
20
0
-20
-40
-60

Distal Inferior
Basal Inferior
Distal Lateral
Basal Lateral
Distal Anterior
Basal Anterior
Distal Septal

I

II

III aVR aVL aVF V1 V2 V3 V4 V5 V6
Leads

Basal Septal
Apex

Figure 2.23 Delta of QT interval of 12 leads from normal model, resulting
from prolonging APD in one region.
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Figure 2.24 Delta of QT interval of 12 leads from normal model, resulting
from shortening APD in one region.

Simulations of hyperinnervation in the basal region complicated by the
loss of innervation in the distal region were simulated by prolonging APD in the
distal region and shortening APD in basal region. Results of QT interval changes
due to this simulation are shown in Figure 2.25. QT interval changes due to
shortening APD in the distal region and prolonging APD in the basal region are
shown in Figure 2.26. The pattern of prolonging APD in the distal, and shortening
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APD in the basal septal region was selected because this modification generated
increases in QT interval of all leads.

Delta of QT, msec

Delta of QT from Normal
Effects of prolonging APD in distal regions (loss of
innervation), and shortening APD in basal regions
(hyperinnervation)
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Figure 2.25 Delta of QT interval of 12 leads from normal model, resulting
from prolonging APD in distal, and shortening APD in basal regions.
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Delta of QT from Normal
Effects of shortening APD in distal regions (loss of
innervation), and prolonging APD in basal regions
(hyperinnervation)
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Figure 2.26 Delta of QT interval of 12 leads from normal model, resulting
from shortening APD in distal, and prolonging APD in basal regions.

Finally, because the distal inferior region has frequenty been reported to
be the first region affected, and an extension from this region has been observed
in patients with more severe neuropathy, simulations of loss of innervation in two
regions, extending from distal inferior to basal inferior, distal septal,distal lateral
or apical regions were performed. In addition, diffuse denervation was also
simulated by changing APD in the whole left ventricle. QT interval changes due
to prolonging APD in these regions are shown in Figure 2.27. QT interval
changes due to shortening APD in these regions are shown in Figure 2.28. The
pattern that prolonged APD at distal inferior and distal lateral regions was
selected because this pattern generated increases in QT interval of all leads.

84

Delta of QT, msec
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Figure 2.27 Delta of QT interval of 12 leads from normal model, resulting
from prolonging APD in two regions or prolonging APD diffusely.
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Figure 2.28 . Delta of QT interval of 12 leads from normal model, resulting
from shortening APD in two regions or shortening APD diffusely.

Twelve-lead ECG of selected patterns were then plotted against normal
12-lead ECG to compare the morpholoy of ECG. Figure 2.29 shows ECGs from
the simulation that prolonged APD in the distal lateral region. Prolonging APD in
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this region resulted in changes in the morphology of ECGs and generated an
inverted T wave in leads V5 and V6.

Figure 2.29 Twelve-lead ECG of the simulation that prolonged APD in the
distal lateral region, plotted against normal ECG.
Figure 2.30 shows ECGs of the simulation that prolonged APD in the
basal septal region. Prolonging APD in the basal septal region preserved the
morphology of ECG.
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Figure 2.30 Twelve-lead ECG of the simulation that prolonged APD in the
basal septal region, plotted against normal ECG.

Figure 2.31 shows ECGs from the simulation that prolonged APD in the
distal lateral region and shortened APD in the basal lateral region. Prolonging
APD in the distal lateral region with shortening APD in the basal lateral region
resulted in changes in the morphology of ECG and generated inverted T wave in
leads V5 and V6.
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Figure 2.31 Twelve-lead ECG of the simulation that prolonged APD in the
distal lateral region and shortened APD in the basal lateral region, plotted
against normal ECG.
Figure 2.32 shows ECGs of the simulation that prolonged APD at distal
inferior and distal lateral regions. Prolonging APD at distal inferior and distal
lateral regions resulted in changes in the morphology of ECG and generated
inverted T wave in leads V5 and V6.
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Figure 2.32 Twelve-lead ECG of the simulation that prolonged APD in the
distal inferior and distal lateral regions, plotted against normal ECG.
Determination of the pattern with the best match. From the comparison of
the change in QT interval and morphology of ECGs, the pattern of prolonging
APD in the basal septal region yielded the best match to experimental data.
Specifically, 1) QT interval increased in all leads, and 2) the morphology of ECG
was preserved. In addition, the minimum QT interval of lateral leads increased by
15 msec, 2 msec longer than from all leads.
Further modifcations. Because in diabetic patients with more severe
autonomic neuropathy, the loss of tracer activity in the same region is more
pronounced and the affected region extends to other regions (91, 93, 113, 123),
the simulations of longer prolongation of APD (60 msec at endocardium and 20
msec at midmyocardim) in the basal septal region, and prolonging APD in
regions near the basal septal region were performed, respectively. QT interval
changes due to prolonging APD in two regions (basal septal and distal septal
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regions, basal septal and basal inferior regions, basal septal and basal anterior
regions) are shown in Figure 2.33. Compared to changing APD in a single basal
septal region, extension of regions did not alter QT intervals of lateral leads
(leads I, aVL, V5 and V6), but other leads. Prolonging APD in the single basal
septal region was chosen to be the pattern that best matched observed results.

Delta of QT from Normal
Effects of prolonging APD in two regions, centered at basal
septal region
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Figure 2.33 Delta of QT interval of 12 leads from the normal model,
resulting from prolonging APD in two regions, extended from the basal
septal region.

QT interval changes due to longer prolongation of APD in the basal septal
region are shown in Figure 2.34. Additional prolongation of APD generated larger
changes in QT interval in most leads.
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Delta of QT from Normal
Effects of prolonging APD with larger APD changes
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Figure 2.34 Delta of QT interval of 12 leads from thenormal model, resulting
from prolonging APD with larger prolongation in the basal septal region.

Intracellular potential and dipoles in normal model and abnormal model. In
order to verify the changes in the forward solution, the cardiac source of modified
model with the chosen pattern was plotted against that of the normal model. The
intracellular potentials of the nine transmural layers (from epicardium to
endocardium) of the left ventricle of the normal model were shown at the top left
side of Figure 2.35, Figure 2.36 and Figure 2.37, for different times. In order to
show the septum, the right ventricle is not included. At the end of the QRS of the
normal ECG, all cell elements were activated and intracellular potentials were
homogeneous (Figure 2.35). At the peak of the T wave, intracellur potentials
were inhomogenous, representing different stages of repolarization (Figure 2.36).
At the end of the T wave, all cell elements were back to resting potentials (Figure
2.37). The intracellular potentials of the left ventricle of the abnormal model,
obtained by prolonging APD in the basal septal region, are shown at the top right
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side of Figure 2.35, Figure 2.36 and Figure 2.37, for different times. At the time of
the end of the QRS of the normal ECG (Figure 2.35), all cell elements were
activated, similar to those of the normal model. At the peak of the T wave (Figure
2.36), repolarizations were more heterogeneous, due to higher potentials in the
basal septal region (red and orange areas). Unlike the normal model, the cell
elements in the basal septal region were still repolarizing at the end of the T
wave (Figure 2.36).
Dipoles and ECG of lateral leads of the normal heart model are also
shown at the bottom of Figure 2.35, Figure 2.36 and Figure 2.37 for different
times. Dipoles were estimated at every cell element as a source of the electrical
field of the extracellular space, and were proportional to the differences of the
intracullular potentials of its six neighbors. Similar to the dipoles shown in the
movie ‘Heart Model and ECG’, the dipoles of one region were averaged and
plotted as a green quiver located at the average of the coordinates of the cell
elements in that region. The average dipole of all cell elements of the heart was
plotted as a red quiver located at the average of the coordinates of all cell
elements. The time at which these plots were made was marked on the ECG of
the four lateral leads.
At the end of QRS, in the normal heart model, the dipoles were small in
amplitude and almost invisible (Figure 2.35, bottom left). It was similar in the
abnormal model (Figure 2.35, bottom right).
In the normal heart model, at the peak of the T wave, the major force of
the heart model, reflected by the red quiver, pointed toward the lateral wall of left
ventricle, generating positive T waves in lateral leads (Figure 2.36, bottom left).
In the abnormal model, although the amplitude of the red quiver was larger, the
direction was similar to that of the normal model, generating a more positive T
wave (Figure 2.36, bottom right).
At the end of the T wave, in the normal heart model, the dipoles again
were small in amplitude and almost invisible (Figure 2.37, bottom left). The
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voltages of normal ECGs were close to zero. In the abnormal model, the major
force was larger than that of the normal model, due to the repolarizing cell
elements at the basal septal region (Figure 2.37, bottom right). The voltages of
the abmormal ECGs were greater than zero.

Figure 2.35 Intracellular potentials of nine transmural layers (from
epicardium to endocardium), dipoles and the ECGs of lateral leads of the
normal model (a, b, c, left) and the abnormal model, obtained by prolonging
APD in the basal septal region (d, e, f, right) at the end of the QRS of
normal ECG.
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Figure 2.36 Intracellular potentials of nine transmural layers (from
epicardium to endocardium), dipoles and the ECGs of lateral leads of the
normal model (a, b, c left) and the abnormal model, obtained by prolonging
APD in the basal septal region (d, e, f, right) at the peak of the T wave of
normal ECG.
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Figure 2.37 Intracellular potentials of nine transmural layers (from
epicardium to endocardium), dipoles and the ECGs of lateral leads of the
normal model (a, b, c left) and the abnormal model, obtained by prolonging
APD in the basal septal region (d, e, f, right) at the end of the T wave of
normal ECG.
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2.5 Chapter Five: Discussion
2.5.1 QT Interval Changes in Diabetic Patients with Autonomic
Neuropathy.
In this study, diabetic patients with severe neuropathy tended to have
longer QTc intervals in lateral leads of 12-lead ECG, compared to those of ablebodied subjects.
It has been reported that diabetic patients with cardiovascular autonomic
neuropathy, diagnosed by two abnormal results in cardiovascular reflex tests,
had longer QTc interval than the control group (51, 83, 125). The association
between QTc interval and the severity of autonomic neuropathy has also been
reported (69, 83, 100). However, Gonin et al reported that 57% of the patients
with cardiovascular autonomic neuropathy had a normal QTc interval (51). In
those studies, the numbers of subjects were greater than that in our study, with
the number of diabetic patients ranging from 73 to 266 patients. In addition, QTc
interval was measured in one ECG lead in those studies. In contrast, in the
present study, QTc intervals were also compared in regional leads recorded in
the 12-lead ECG. This resulted in a more significant group difference in the
minimum QTc interval of lateral leads when comparing diabetic patients with
severe neuropathy to able-bodied subjects. Therefore, minimum QTc interval of
lateral leads in 12-lead ECG may be more diagnostic that that of a single lead.
Veglio et al reported that, in 3,250 insulin-dependent diabetic patients,
prolonged QTc interval, measured on V5 lead of resting ECG, was more
prevalent in female subjects, resulting in longer QTc in female, than in male,
subjects (126). However, in the same study, the relation between QTc
prolongation and autonomic neuropathy was not observed among females
although it was observed among males. In our study, diabetes without
neuropathy were dominated by female subjects (5 of 6 subjects were female).
Therefore, the tendency for diabetics without neuropathy to have longer QTc
interval than diabetics with neuropathy may be due to this gender difference
(Figure 2.38).
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Figure 2.38 Gender differences in QTc interval of lead V5 for able-bodied
subjects (AB), diabetics without neuropathy (D0), diabetics with mild
neuropathy (D1) and diabetics with severe neuropathy (D2).

Conversely to prolongation of QTc interval, Ong et al reported a higher
heart rate and shorter QTc interval in diabetic patients with autonomic
neuropathy, diagnosed by reduced heart rate variability (98). However, different
from our study, they recorded a much longer data record, one that lasted for 24
hours.
2.5.2 Regional Sympathetic Denervation to Left Ventricle in Diabetic
Patients
In studies of MIBG-SPECG or HED-PET images, which reveal
sympathetic innervation to the left ventricle, diabetic patients without or with mild
autonomic neuropathy demonstrate low uptake of tracer in the posterior wall (112,
113), posterior-inferior wall (91), inferior wall (56, 93), distal inferior wall (123)
and to a less extend, septal wall (114). In diabetic patients with autonomic
neuropathy, the defects in these regions were more pronounced and extended to
other areas (91, 93, 113, 123). It has also been reported that reduced uptake of
tracer was observed in anterior, lateral and apical regions (75, 115). In addition,
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Claus et al reported a lack of tracer activity in dorso-septal region in diabetic
patients, within whom 79% had somatic polyneuropathy (22). The finding of a
defect in the dorso-septal region agreed with the simulations of the present study.
The similarity between the defect region in the study of Claus et al and this study
may be due to a similar stage of neuropathy in both studies of diabetic patients
with polyneuropathy.
2.5.3 Mechanisms of QT Interval Prolongation in Diabetic Neuropathy
This simulation study suggested that different patterns of regional
prolongation of APD in the left ventricle caused changes in QT intervals of 12lead ECG. It has been reported that regional defects in MIBG uptake was not
correlated with QTc interval in diabetic patients (22, 112-114). However, in those
studies, ECG was recorded in one lead. In fact, in the current simulation study,
there were relatively smaller increases or even decreases in QT interval of lead II
when prolonging APD. These results were seen in many patterns (for example, 1)
those involving distal inferior, basal inferior, distal anterior, basal anterior, or
basal lateral regions, 2) with complications of hyperinnervation in inferior, anterior
or septal regions, and 3) in two regions involving distal inferior, basal inferior,
distal anterior and distal septal regions). Therefore, QTc interval of lead II may
not be reflective of most patterns of regional denervation. Another possibility is
that QTc interval of lead II is reflective of a more severe autonomic neuropathy,
since QT interval was correlated with abnormal results in cardiovascular reflex
tests, which is known to represent a more severe neuropathy (49). In this
simulation study, increases in APD prolongation led to increases in QT interval
prolongation of lead II (Figure 2.34), although extension of affected area did not
have an effect on lead II ECG (Figure 2.33).
2.5.4

Limitations

Movement of the heart during contraction and relaxation was not
considered in this model, which may influence the results of the morphology of
the modeled ECG. In addition, the lack of effects of muscle orientation on the
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propagation of excitation, the simplicity of the structure of the ventricles, and the
assumption of an homogeneous conductor in the torso may also explain
differences in the detail of the morphology of the ECG and the QT interval pattern
of 12 leads, between the model and able-bodied subjects. In addition, the lack of
direct comparison of simulation results with individual cardiac denervation pattern
from cardiac images limits the interpretation of results. However, this model
demonstrates the feasibility of using forward and inverse solutions to detect
cardiac sympathetic denervation.
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2.6 Chapter Six: Conclusions
Diabetic patients with severe neuropathy tended to have longer QTc
intervals in 12-lead ECG. The minimum QTc interval of lateral leads was more
diagnostic than that from other leads. The change of QTc interval in diabetic
patients with severe neuropathy compared to able-bodied subject may be due to
a mechanism involving prolongation of APD at the basal septal region, due to
cardiac sympathetic denervation.
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2.7 Chapter Seven: Future Work
Validation studies need to be performed by collecting MIBG-SPECT images
and QT intervals in 12-lead ECG in diabetic patients. Results from these data
sets would be used to verify the model. In addition, the inverse solution from
body surface potential acquired from more electrodes could provide the potential
to locate cardiac sympathetic denervation, and thus provide a time efficient and
cost effective method to detect cardiac denervation in diabetic patients. Finally,
refining the model by adding complexity (for example, inhomogeneity of the torso
or orientation of muscle fibers) may improve the similarity between the model and
a real heart.
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